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ABSTRACT 
!
Macrophages are important mediators of innate immunity and nutritional immunity via 
modulation of essential nutrients like iron during bacterial infection. Ferroportin (Fpn), an 
iron-exporting protein, is found on the plasma membrane of macrophages and, if not 
modulated during phagocytosis, would transport iron into phagosomes and supply 
phagocytosed bacteria with iron. Interestingly, the fate of Fpn during phagocytosis and 
bacterial infection remains unknown. I generated a Fpn-GFP fusion protein and, using 
fluorescence microscopy, demonstrated that, during phagocytosis in RAW264.7 
macrophages, Fpn is removed from phagosomes containing IgG-coated beads or 
Staphylococcus aureus. Further, Fpn is present on Rab5-containing phagosomes but 
absent from PI(3)P- and LAMP1-positive phagosomes indicating Fpn removal occurs 
early during phagosome maturation. Co-localization analysis revealed that markers of 
cellular recycling pathways, Rab4 and transferrin receptor, do not co-localize with Fpn. 
Thus, my data support the conclusion that macrophages restrict Fpn residence on 
phagosomes presumably to prevent iron transport into phagosomes. 
 
 
Keywords: iron, ferroportin, trafficking, macrophages, phagocytosis, nutritional 
immunity 
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CHAPTER 1 – LITERATURE REVIEW 
 
1.1 Introduction to innate immunity  
Innate immunity is the first line of defense against invading pathogens and provides an 
immediate yet relatively short-lived defense against infection. Components of innate 
immunity include anatomical barriers, the microbiome, complement, nutrient restriction,  
and phagocytes, as have been previously reviewed (1–5). Infection occurs following a 
breach in the gastrointestinal, urogenital, respiratory tract, or the skin epithelium. The 
host attempts to prevent infection in multiple ways. For example: to prevent bacterial 
attachment, mechanical forces, such as the movement of cilia and air flow in the 
respiratory tract or the clearance of urine in the urogenital tract, are employed. Further, 
chemical cues such as antimicrobial peptides on the skin and acidic pH in the  
gastrointestinal tract limit bacterial growth. Colonization with commensal bacteria 
provides an additional barrier to invading microbes by competing with invading microbes 
for attachment sites and nutrients in a process termed colonization resistance (2, 6). 
Augmentation of anatomical barrier function is provided by the humoral aspect of 
innate immunity which involves for example, the deposition of complement on invading 
microbes (3). Complement proteins are found in the circulation in inactive forms and 
recognize pathogens using highly conserved pathogen-associated molecular patterns 
(PAMPs). When recognized, the complement protein C3 is deposited onto the microbial 
surface and activated, thereby targeting the microbe for lysis or ingestion by phagocytes.  
While crucial to innate immunity, complement was originally named due to the 
functional complementation it provides phagocytes – a component of innate immunity 
important to this project. Phagocytes are absolutely essential to the immune system as 
their bactericidal function is a crucial part of the innate immune system and also provides 
a link to adaptive immunity by initiating its activation (5).  
The final component of innate immunity is nutrient restriction. Nutrient restriction 
includes the purposeful withholding of essential nutrients, such as iron and manganese, 
by the host to limit pathogen growth. The many mechanisms of nutrient withholding 
during bacterial infection are collectively referred to as nutritional immunity (4, 7). 
Important to this project is the intersection between phagocytes and nutritional immunity, 
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specifically concerning iron, and these components are reviewed in more detail below.   
 
 
1.2 Iron  
Iron is one of the most abundant elements on Earth (8) and is an essential nutrient for 
nearly all life forms – one of the only known exceptions being the microorganism 
Borrelia burgdorferi (9). Iron plays a key role in many cellular processes for both the 
host and pathogenic microbes. Many iron-requiring processes are essential for survival 
and include oxygen transport, cellular respiration, cell cycle control, and DNA replication 
and repair (10, 11). The ability of iron to act in such diverse processes is due to the redox 
potential it provides by alternating between ferrous (Fe2+) and ferric (Fe3+) states, with a 
redox that spans approximately 1 volt. While bacterial iron homeostasis and acquisition 
are briefly reviewed in a later section (section 1.2.6), for the purposes of this study, the 
focus is on the roles of iron and iron-binding proteins in host processes. 
 
1.2.1 Host iron binding proteins  
Generally, iron is found throughout the body in one of two forms: heme-iron or non-heme 
iron. Heme-iron is one of the most physiologically important forms of iron and is also the 
most abundant, making up approximately 60% of total iron in the human body. 
Structurally, heme consists of a planar porphyrin ring which allows for the coordination 
of one ferrous iron atom via four nitrogen atoms (12) and is incorporated into many 
enzymes as a cofactor (13, 14). The heme-iron complex is utilized in many processes, the 
most notable being oxygen transport. Erythrocytes contain high levels of hemoglobin, a 
heme binding protein. Binding to heme allows hemoglobin to bind to oxygen and 
facilitate delivery of oxygen from the lungs throughout the tissues. Other heme utilizing 
proteins include myoglobin, which acts similarly to hemoglobin but in muscle tissue, and 
cytochrome c oxidase, a molecule found in both bacterial and eukaryotic electron 
transport chains that aids in establishing a proton gradient for ATP synthesis.  
Some proteins utilize iron in forms such as iron-sulfur clusters. Iron-sulfur 
clusters are protein co-factors that co-ordinate iron using cysteine residues (15). The 
electron transport flavoprotein ubiquinone-oxidoreductase is a component of the 
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mitochondrial respiratory chain that utilizes iron-sulfur clusters to mediate transfer of 
electrons into the ubiquinone electron pool (16).  
Other major sources of non-heme iron include ferritin and transferrin. Ferritin is 
the primary intracellular iron storage protein for both bacteria and eukaryotes (17). It is a 
globular protein composed of 24 subunits that forms a nanocage capable of internalizing 
and oxidizing ferrous iron and storing ferric iron. Iron storage by ferritin is important not 
only to prevent loss of iron but also to prevent formation of hydroxyl radicals (discussed 
in 1.2.2). Further, in iron deficient conditions, ferritin is degraded in lysosomes to yield 
an iron source (18). Transferrin (Tfn) is a glycoprotein found in the blood that can bind 
two atoms of ferric iron with high affinity (19, 20). Like ferritin, Tfn is important for 
maintaining iron in the non-toxic ferric form but also in facilitating cellular iron uptake 
and transporting iron from sites of absorption throughout the body.  
 
1.2.2 Iron toxicity 
Despite its importance to cellular function, cellular levels of free iron are strictly 
maintained to prevent cellular toxicity. This toxicity is due to the iron-dependent Haber-
Weiss reaction that produces reactive oxygen species. The Haber-Weiss reaction consists 
of two parts, one of which utilizes Fenton chemistry: the reaction of ferrous iron (Fe2+) 
and hydrogen peroxide (a by-product of aerobic respiration) to generate hydroxyl 
radicals, as shown in Equation 2 (21, 22).  
 
Equation 1.      Fe3+ + • O2- ! Fe2+ + O2 
Equation 2. Fenton Reaction.   Fe2+ + H2O2 ! Fe3+ + OH• + OH-   
Net     • O2- + H2O2 ! O2 + OH• + OH- 
 
Reactive oxygen species, including hydroxyl radicals, are powerful oxidizing agents that 
damage various biological molecules including lipids, proteins, and nucleic acids (23–
25). This eventually leads to loss of molecular function and, ultimately, cellular death 
(26). For this reason, the host utilizes many mechanisms to rigorously limit cellular levels 
of free iron.  
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1.2.3 Host cellular iron homeostasis 
Because of both its potential toxicity and its importance for cellular function, the host has 
evolved sophisticated mechanisms to strictly regulate iron absorption, transport, storage 
and utilization at the cellular level. The average human body contains between 3-5 g of 
iron which is obtained exclusively from dietary sources. Non-heme iron and heme-iron 
are absorbed into cells of the intestine using the importing proteins divalent metal 
transporter 1 (DMT1) (27, 28) and heme carrier protein 1 (HCP1) (29), respectively. 
DMT1 and HCP1 are membrane proteins expressed in the apical surface of epithelial 
cells in intestinal villi. Heme uptake is mediated by HCP1 (30, 31) and, while 
intracellular trafficking mechanisms of heme are poorly understood, once inside the cell 
heme is degraded via heme oxygenase thereby releasing iron which is then bound by the 
iron chaperone protein PCBP2 (poly(rC)-binding protein 2) (32, 33). Conversely, DMT1 
binds to free iron and transports it into the cell which is then bound by PCBP2. PCBP2 
shuttles imported iron to the storage protein ferritin or to the iron exporting protein called 
ferroportin (Fpn). Fpn is located at the basolateral membrane of intestinal epithelial cells 
where it exports iron out of the cell and into the blood (34–36). Interestingly, there is no 
known regulated, physiological means of excreting iron for the purposeful loss from the 
body. The only loss, apart from bleeding, is minimal and occurs via the sloughing of cells 
from epithelial surfaces like the skin and the gastroenteric/genitourinary tracts.  
Due to the absence of a controlled excretion mechanism, the levels of cellular iron 
are strictly maintained by controlling absorption in the intestines and transport into 
circulation. During iron-limited conditions the expression of DMT1 increases in the 
duodenum to allow for increased absorption (37). Further, iron stored intracellularly in 
ferritin can be accessed by enhancing proteolytic degradation of ferritin (18). 
Alternatively, in iron-replete conditions, levels of Fpn expression at the membrane are 
decreased to prevent iron export into the circulation (38). This event is mediated by the 
peptide hepcidin which is the master regulator of systemic iron homeostasis (39).  
 
1.2.4 Systemic iron homeostasis and the macrophage 
In addition to maintaining cellular levels of iron, it is also imperative to regulate iron 
levels systemically. A key mediator of this process is the macrophage as they are 
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responsible for iron recycling via erythrophagocytosis (40). Erythrocytes represent the 
largest pool of iron within the human body due to the large amounts of hemoglobin 
contained within these cells (41). The large volume of hemoglobin enables erythrocytes 
to circulate throughout the body and deliver oxygen to tissues for up to 120 days at which 
point erythrocytes are recycled. 
 Macrophages, particularly in the spleen and liver, recognize senescent 
erythrocytes, internalize them via phagocytosis and then proteolytically degrade the 
internalized cell. Degradation allows the macrophage to extract iron from the cell and 
shuttle iron into different pathways. Iron may be exported out of the macrophage and into 
the circulation via Fpn, which is also expressed on the plasma membrane of macrophages 
(42). Once in circulation, iron is bound by Tfn and transported between sites of utilization 
and storage, mainly in hepatocytes and liver macrophages. Most of the recycled iron is 
supplied to erythrocyte precursor cells in the bone marrow.  
In addition to iron recycling via erythrophagocytosis, macrophages also play a 
role in systemic iron regulation via interaction with hepcidin (43). Hepcidin is a 25-amino 
acid peptide hormone produced by the liver and is the primary regulator of iron 
absorption and distribution throughout the tissues (44). Iron excess stimulates production 
of hepcidin which then results in the internalization of Fpn (38). This decreases iron 
transport from macrophages into the circulation. Alternatively, iron deficiency inhibits 
hepcidin production which allows the release of iron stored within macrophages.   
 Macrophages play another important role in iron homeostasis in that they aid in 
generating hypoferremia during bacterial infection. This aspect of iron homeostasis is 
discussed further in later sections of this review (section 1.3.4). Nevertheless, 
maintenance of iron homeostasis is a complex process involving many factors at both 
cellular and systemic levels, many of which are mediated functionally by macrophages. 
Accordingly, disturbances in homeostasis can have potentially serious consequences.   
 
1.2.5 Iron-related diseases 
Iron is essential for cellular function and, as such, when iron homeostasis is disrupted 
serious disease can result. Iron-related diseases generally fit into one of two categories: 
iron overload or iron deficiency. Iron deficiency, one of the most common nutrient 
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deficiencies in the world, is generally caused by inadequate dietary intake (45). It can 
also be caused by an alteration in iron absorption due to the presence of certain 
substances such as the antibiotic fluoroquinolone. Fluoroquinolone is an iron chelator and 
therefore its presence in the intestine can result in reduced iron absorption (46). Chronic 
iron-deficiency can lead to anemia which is a decrease in red blood cells or hemoglobin 
in the blood.   
Conversely, iron-overload diseases are often hereditary but can also be caused by 
repeated blood transfusions (47). One branch of inherited iron-overload disease is 
hereditary hemochromatosis (HH). There are four types of HH and they are categorized 
as follows: types 1 through 4 caused by mutations in genes HFE (encoding the human 
hemochromatosis protein) (48), HAMP (encoding hepcidin) (49), TFR2 (encoding 
transferrin receptor 2) (50), or SLC40A1 (encoding Fpn) (51, 52), respectively. HH type 
4, sometimes referred to as Fpn disease, is discussed in more detail in section 1.4.4. 
Pathologically, iron-overload can cause cellular structural damage from physical 
accumulation of iron within the cell and oxidative damage due to the iron-mediated 
production of reactive oxygen species (25).  
  Interestingly, iron-overload diseases also have implications in susceptibility to 
infection. Patients with HH are more susceptible to infection by many different pathogens 
including by Vibrio vulnificus (53), Yersinia enterocolitica (54), and Listeria 
monocytogenes (55). Further, patients with iron-overload due to repeated blood 
transfusions also experience increased susceptibility to infection as well as increased 
severity of infection (56, 57) highlighting both the importance of iron homeostasis in the 
host but also, as mentioned above, the importance of iron to bacteria.  
 
1.2.6 Bacterial iron acquisition 
Iron is essential to many biological processes in bacteria including cellular respiration, 
electron transport, and DNA replication and repair. Environmental concentrations of free 
iron are relatively low since, at neutral pH in the presence of oxygen, iron precipitates. 
Moreover, in the context of infection, the host has evolved many mechanisms of iron-
withholding to further reduce environmental concentrations of iron (discussed in depth in 
section 1.3). Like the host, iron concentrations within bacterial cells must be strictly 
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regulated since high concentrations can be toxic (discussed in section 1.2.3). As such, 
bacteria have evolved sophisticated iron-acquisition strategies that allow them to regulate 
iron import and overcome iron-limitation within the host (58).  
Pathogens utilize transcriptional regulators to sense environmental iron and 
regulate gene expression accordingly. Gram-negative and some Gram-positive bacteria, 
such as Staphylococcus spp., utilize the ferric uptake regulator (Fur), an iron-sensing 
mechanism conserved across many bacterial species (59). Several mechanisms exist in 
bacteria for iron sensing, however, by far the most studied mechanism is through the 
activity of Fur. In iron-replete conditions, Fur is bound to ferrous iron as its corepressor. 
Iron-binding induces a conformational change in Fur allowing it to bind DNA and 
prevent target gene expression. In iron-limited conditions, Fur is not bound to iron and 
therefore does not bind DNA and repress gene expression. Many of the genes regulated 
by Fur relate specifically to iron acquisition, but some also relate to virulence, biofilm 
formation and the expression of anti-oxidative stress proteins (60).  
Bacterial iron acquisition falls into generally one of three categories: heme-iron 
acquisition, siderophore-mediated iron acquisition, and free iron uptake. Heme-iron 
acquisition involves the extraction of heme or heme-binding proteins from sources within 
the host, transport of heme into the bacterial cell and eventual degradation of the heme 
moiety to release iron for bacterial use. A major heme acquisition mechanism in S. 
aureus and other Gram-positive pathogens is the Isd (iron-regulated surface determinant) 
system (61). Further, several bacterial pathogens use secreted heme-binding proteins, 
called hemophores, to bind heme and deliver it back to the bacterial surface for eventual 
transport. Another major iron-acquisition strategy of bacteria involves siderophores. 
Siderophores are secreted, low-molecular weight, high affinity iron chelators. In response 
to iron deprivation, bacteria secrete siderophores to scavenge residual free iron in the 
environment and to appropriate Tfn- and lactoferrin-bound iron. The last iron acquisition 
strategy employed by pathogens is the uptake of free iron. These mechanisms of uptake 
have been sparsely investigated due to the relative lack of freely available iron, however, 
some iron transporters have been identified. Gram-negative pathogens like Legionella 
pneumophila and, purportedly, some Gram-positive pathogens utilize the ferrous iron 
importer FeoAB for iron acquisition (62, 63). This system is regulated by Fur in Gram-
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negative bacteria. Using transcriptional regulators like Fur enables bacteria to sense the 
bioavailability of iron and regulate iron acquisition systems accordingly.  
In addition to iron acquisition genes, Fur regulates genes involved in virulence. In 
iron-limited conditions, Fur-mediated de-repression of transcription allows the production 
of secreted virulence factors. For example, S. aureus secretes hemolysins and cytotoxins 
which ultimately results in release of iron and iron sources thereby promoting bacterial 
survival and transmission (60).  
Iron is indispensable for virtually all life forms, a fact that is aptly demonstrated 
by the impressive diversity of iron-requiring host processes. Bacterial pathogens also 
have a requirement for iron, and have evolved sophisticated mechanisms to overcome 
iron restriction. The host places tremendous importance on its ability to withhold iron 
(and other metals like zinc and manganese) from invading pathogens, in a process 
collectively referred to as nutritional immunity. These processes are discussed in the 
following sections.  
 
 
1.3 Nutritional Immunity  
Nutritional immunity refers to the processes whereby the host sequesters the availability 
of essential nutrients in order to combat the nutrient acquisition strategies of pathogens, 
curtail microbial growth and ultimately promote pathogen clearance (4). Transition 
metals like iron are not only essential for host biology but are also critical for microbial 
survival and replication. Therefore, in nutritional immunity, the sequestered nutrients 
consist largely of transition metals such as iron, manganese, and zinc. Further, the 
regulatory mechanisms used to reduce iron toxicity also play roles in nutrient restriction 
during bacterial infection.  
 
1.3.1 Iron restriction in the host 
The primary method of iron sequestration within the host is that most iron in the body is 
stored intracellularly complexed with other proteins. As discussed previously, ferrous 
iron is complexed with heme which is bound by hemoglobin in erythrocytes (64) and 
ferric iron is stored intracellularly bound by ferritin. However, many pathogens have 
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evolved effectors of erythrolysis such as the Staphylococcus aureus α-toxin which lyses 
red blood cells to release the large pool of stored iron (65). When this occurs the host 
uses glycoproteins like hemopexin and haptoglobin, which are circulating in the serum, to 
scavenge heme and hemoglobin, respectively (66). Another factor limiting iron 
availability to pathogens is the scarcity of free iron in the extracellular environment. This 
is due to iron being tightly bound to Tfn in circulation. Generally, Tfn levels are 
maintained so that approximately half of circulating Tfn is saturated. This allows 
immediate sequestration should free iron unexpectedly become available, such as from 
erythrolysis during infection.  
At mucosal surfaces, the host utilizes the glycoprotein lactoferrin, produced by 
neutrophils and epithelial cells, to bind and therefore sequester ferric iron (67–69). 
Additionally, once at infectious foci, neutrophils release neutrophil gelatinase-associated 
lipocalin (NGAL, or Lipocalin 2) which binds to and sequesters bacterial catechol-type 
siderophores (70). Recall, siderophores are small, high-affinity ferric iron binding 
molecules secreted by bacteria that aid in bacterial iron acquisition. In addition to 
reducing iron availability via binding proteins, the host also utilizes transport mechanisms 
to alter iron distribution during infection.  
 
1.3.2 NRAMP1 
One mechanism of altering iron distribution during infection is the utilization of metal 
transporters to pump nutrients away from bacteria-containing compartments. One such 
transporter is the membrane protein natural resistance-associated macrophage protein 1 
(NRAMP1). NRAMP1 was originally discovered due to the natural resistance expression 
of NRAMP1 provided during infection caused by the pathogens Salmonella typhimurium, 
Leishmania donovani and certain Mycobacterium species (71).  NRAMP1 (encoded by 
the human gene SLC11A1) is an integral membrane protein that transports divalent 
cations (72). It is expressed primarily in professional phagocytes, particularly from the 
spleen and liver, but has recently been discovered to be expressed in lymphocytes as well 
(73). NRAMP1 localizes to late endocytic compartments within the cell and is 
specifically recruited to phagosomal membranes in macrophages (74, 75) where it works 
to extrude ions like Mn2+, Zn2+, and Fe2+ out of the phagosome lumen (76–78). This 
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action limits the availability of these essential nutrients to phagocytosed bacteria and 
controls bacterial infection.    
 
1.3.3 DMT1 
Another metal transporter implicated in nutritional immunity is the iron-transporting 
protein DMT1. DMT1 (also known as NRAMP2, DCT1, encoded by the human gene 
SLC11A2) is also a divalent cationic metal transporting protein with an unusually broad 
substrate range including Fe2+, Zn2+, Mn2+, Co2+, Cd2+, Cu2+, Ni2+, and Pb2+ (28). As 
discussed previously (section 1.2.3), DMT1 is involved in iron uptake in the duodenum 
however it is also present at the plasma membrane, early and late endosomes in many 
cells types (79, 80). One recent study demonstrated that upon infection by uropathogenic 
E. coli, macrophages upregulate DMT1 expression at the plasma membrane which 
presumably results in increased iron uptake and therefore limits the availability of iron to 
extracellular E. coli (81). While the role of DMT1 in infection hasn’t been studied 
extensively, considering the functional similarity of DMT1 to NRAMP1, it is likely that 
DMT1 also contributes to nutrient restriction during infection, particularly in cells that do 
not otherwise express high levels of NRAMP1. 
 
1.3.4 Inflammatory hypoferremia 
During infection the host regulates the production or activity of iron-related proteins to 
generate a hypoferremic environment within the body in a process called inflammatory 
hypoferremia (82). Induction of inflammatory hypoferremia is mediated by cytokines, 
such as interferon (IFN)-" and interleukin (IL)-6, and hepcidin which are produced in 
response to infection. Increased hepcidin production results in increased degradation of 
Fpn thereby reducing export of iron into circulation, retention of iron intracellularly, and 
decreased availability of iron to extracellular bacteria. IFN-" and IL-6 induce the acute 
phase response which results in increased production of iron-scavenging proteins such as 
lactoferrin, haptoglobin and ferritin (83), as discussed above. Hypoferremia during 
infection has long been recognized and investigated but more recently there has been 
renewed interest in nutritional immunity concerning other essential transition metals.  
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1.3.5 Manganese and zinc binding proteins  
Like iron, other transition metals such as zinc and manganese play critical roles in host 
and bacterial processes. Among other enzymes, the enzyme superoxide dismutase 
requires manganese as a cofactor and is very important for resistance to oxidative stress 
for both the host and bacteria (84). Zinc is the second most abundant transition metal 
after iron in both the host and bacteria. It is critical in immune regulation, signal 
transduction and apoptosis in the host and plays important catalytic and structural roles in 
bacteria (85). As such, both manganese and zinc are also important targets for nutritional 
immunity (86).  
One of the key mediators of zinc restriction and the only known chelator of 
manganese is calprotectin (CP) (87). CP is a heterodimer consisting of the proteins 
S100A8 and S100A9: both members of the S100 family of calcium-binding proteins. The 
antimicrobial activity of CP is mediated by binding of calcium to S100A8 and S100A9. 
Calcium binding induces conformational changes in the proteins allowing high affinity 
binding to either one manganese atom or two zinc atoms at the interface of the two 
subunits (88). CP is abundant in the cytoplasm of neutrophils and is released at the site of 
infection via degranulation and neutrophil extracellular traps (NETs). As neutrophils are 
the first responders to sites of infection, CP plays an important role in the immediate 
defense against invading pathogens. Specifically, CP displays dose-dependent 
antimicrobial activity against S. aureus in a tissue abscess model (89) and also is the key 
mediator of the antifungal properties of NETs (90, 91).  
Other members of the S100 family of proteins include S100A7 (also known as 
psoriasin) and S100A12 (also known as calgranulin C and EN-RAGE). S100A7 is a 
protein found on healthy human skin that mediates killing of E. coli via sequestration of 
zinc (92). S100A7 production is enhanced in hyperproliferative skin diseases such as 
psoriasis and has also been implicated in strengthening epithelial tight junctions. This 
presumably enhances skin innate barrier function by impeding the entrance of invasive 
microbes (93).  S100A12 is yet another zinc chelating protein produced by neutrophils 
and has been shown to have antibacterial effects against Helicobacter pylori (94), and 
Listeria monocytogenes and also antifungal effects against Candida albicans (95).  
CP, S100A7, and S100A12 each bind zinc and while this seems functionally 
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redundant it serves to highlight the importance of zinc limitation during infection. 
Further, since both CP and S100A12 are housed in neutrophils and released at the site of 
infection, it has been proposed by Cunden et al (2016) that S100A12 chelates a portion of 
the zinc pool to allow more CP molecules to bind to manganese (95). In addition to iron, 
manganese, and zinc, copper is another transition metal implicated in nutritional 
immunity. However, copper distribution seems to be altered in a manner opposite to that 
of the transition metals already discussed.   
 
1.3.6 Copper transporting proteins 
Just like the previous transition metals discussed, copper is a critical component of 
proteins involved in many cellular processes and at high concentrations has toxic effects. 
In fact, the toxic and therefore antimicrobial properties of copper have long been known 
and exploited ex vivo. Copper is used in plumbing for its antimicrobial properties (96, 97) 
and currently there is interest in using copper on hospital surfaces to reduce occurrence of 
nosocomial infections (98). Due to these properties, copper also plays a role in nutritional 
immunity.  
However, in contrast to the withholding mechanisms used for iron, manganese, 
and zinc, evidence has emerged that the host specifically utilizes copper to exert an 
antimicrobial effect on invading pathogens. In response to pro-inflammatory stimuli IFN-
γ and LPS, macrophages upregulate expression of CTR1 and ATP7A (99). Both CTR1 
and ATP7A are copper-transporting proteins. CTR1 (SLC31A1) functions at the plasma 
membrane of macrophages as a copper importer (100). Conversely, ATP7A is copper 
transporter localized to both the plasma membrane where it exports copper and also to 
endocytic compartments within the cell where it pumps copper into intracellular vesicles 
(101). During inflammation, cellular copper uptake is increased, presumably through 
CTR1, and the copper binding protein ATOX1 shuttles copper to ATP7A (102). ATP7A 
then pumps copper into phagosomes for intoxication of phagocytosed bacteria. 
Accumulation of copper within the phagosome has been shown to have bactericidal 
effects against E. coli (99) and M. tuberculosis deficient in copper efflux (103).  
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1.4 Ferroportin  
!
1.4.1 Function and structure  
Another metal transporter implicated in nutritional immunity and of particular interest to 
this study is Fpn. Ferroportin (also known as SLC40A1, IREG1 and MTP1) is the only 
known mammalian iron-exporting protein (34–36) and is part of the major facilitator 
superfamily (MFS) of transporting proteins. In addition to iron transport, Fpn has recently 
been shown to have cobalt, zinc, and manganese transport activity as well (104, 105). Fpn 
is expressed in tissues involved in iron homeostasis, namely duodenal enterocytes, 
hepatocytes, and macrophages where it plays a role in iron absorption, storage, and 
recycling, respectively (106). Fpn is also critical during fetal development for 
transporting iron though the placenta to the fetus as demonstrated by the non-viability of 
mice lacking Fpn (107).  
Fundamental information about the structure of Fpn has been controversial. 
Certain groups described the topology of Fpn with either one or both of the N- and C-
termini to be extracellular (108, 109) while others described either one or both of the N- 
and C-termini to be intracellular (110, 111). Further, the number of transmembrane 
domains Fpn contains was debated, with groups predicting the presence of either ten (36) 
or twelve (110) transmembrane domains. However, several models based on other MFS 
transporters with twelve transmembrane domains suggest that both termini of human Fpn 
are intracellular (112–114). Moreover, Taniguchi et al (2015) (115) used a putative 
bacterial homologue of Fpn from Bdellovibrio bacteriovorus to obtain crystal structures 
revealing two 6-helix bundles characteristic of the MFS proteins (116). The structures 
revealed two states: an inward and outward facing state in which a cleft, presumably the 
metal binding site, is exposed to the inside or outside of the cell, respectively.  
 
1.4.2 Mechanism of iron binding and transport 
While the mechanism of iron binding and transport hasn’t been determined conclusively, 
some information is known. Within the cell, PCBP2 (mentioned in 1.2.4) shuttles ferrous 
iron to Fpn for export (33, 117). Beyond this, the actual molecular mechanism of iron 
transport by Fpn remains largely unknown due to difficulties in crystallizing the human 
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protein. Based on the crystal structures from the bacterial homologue, Taniguchi et al 
(2015) (115) propose that in human Fpn, the iron atom is coordinated by one asparagine, 
one aspartic acid and two serine residues. They also propose a model of the transport 
cycle in which iron binding results in conformational changes in the alpha-helices from 
the inward to the outward facing state thereby facilitating export. It has also been 
proposed that once outside the cell, ceruloplasmin is responsible for oxidizing ferrous 
iron to ferric iron to allow binding to Tfn (118). However, it still has not been 
conclusively determined what form of iron Fpn transports or if there is antiporter or 
symporter activity associated with Fpn. Further investigation is required confirm the 
proposed mechanism of transport (115) . 
 
1.4.3 Ferroportin regulation 
Fpn has many mechanisms of regulation that allow for differential expression between 
different tissues. Fpn is regulated transcriptionally based on the presence of heme. Heme 
causes the degradation of the repressor Bach1 which in turns allows transcription to occur 
via Nrf2 (119, 120). Additionally, the production of NO acts to up-regulate Fpn 
expression also using Nrf2-mediated transcription (121).  
Fpn expression is regulated at the translational level using the iron-responsive 
element (IRE) located at the 5’ untranslated region of Fpn mRNA. Under conditions of 
iron deficiency, iron-responsive proteins (IRP) bind to IREs and cause translational 
repression (122).  
Further, Fpn is regulated post-translationally by the hormone hepcidin. Recall, 
hepcidin is a small peptide produced by the liver that regulates intestinal iron absorption 
and iron recycling by macrophages (39, 123). During inflammation, hepcidin is produced 
and binds to Fpn thereby causing its internalization and subsequent degradation (38, 107, 
124). The mechanism of hepcidin-mediated degradation of Fpn occurs as follows: 
hepcidin binds to Fpn, which is then ubiquitinated and internalized (124) and 
subsequently shuttled through the multivesicular body pathway (125) for degradation by 
the lysosome (38).  
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1.4.4 Ferroportin-related diseases 
Since Fpn plays a central role in iron homeostasis it follows that misregulation of Fpn 
expression or changes in Fpn function can lead to disease. Mutations in the gene 
encoding Fpn result in HH type 4, sometimes referred to as Fpn disease. Reported 
mutations in Fpn are heterogeneous but, despite the heterogeneity, the diseases typically 
present as one of two phenotypes (126). Some mutations result in a “gain-of function” 
phenotype in which Fpn is resistant to hepcidin leading to increased absorption of dietary 
iron, oversaturation of plasma Tfn, and ultimately iron overload (127). This disease more 
closely resembles the other HH discussed in section 1.2.5.  
Alternatively, some mutations lead to a loss-of-function phenotype in which iron 
export via macrophages is reduced (128). This disease presents with iron overload in 
macrophages, increased serum ferritin concentrations but normal Tfn saturation. It is 
presumed that even though macrophages ultimately become iron over-loaded, because 
they have an extensive repertoire of mechanisms to deal with reactive oxygen species the 
iron-overload is not extensively pathogenic. Thus, this form of Fpn disease does not seem 
to cause clinically important damage.  
 
1.4.5 Ferroportin and infection 
Fpn is also important during infection. As discussed, hepcidin production is up-regulated 
during infection resulting in Fpn degradation and cellular iron retention. Cellular iron 
retention is crucial to restricting infection by the extracellular, iron-dependent pathogen 
Vibrio vulnificus (82). Mice lacking hepcidin, in which Fpn export is unrestricted, were 
significantly more susceptible to infection compared to WT mice. Further, mouse 
survival was restored upon supplementation with hepcidin peptides demonstrating the 
importance of Fpn during infection with extracellular bacteria.  
 Another facet of investigation is the role of Fpn during infection with intracellular 
pathogens, especially concerning macrophages. For instance, macrophages infected with 
S. typhimurium have increased Fpn mRNA expression indicating macrophages increase 
iron export during S. typhimurium infection (129). This directly contrasts the observed 
hepcidin-mediated cellular iron retention in hypoferremia of inflammation. Similarly, in 
macrophages infected with WT L. monocytogenes, Fpn mRNA levels significantly 
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increased compared to the static Fpn mRNA levels observed in cells infected with a strain 
defective in phagosome escape (130). The increase in Fpn expression corresponded to 
decreased bacterial CFUs and conversely, treatment with hepcidin lead to increased 
bacterial CFUs.  Further, Fpn over-expression in macrophages has been demonstrated to 
limit intracellular growth of M. tuberculosis, presumably by restricting iron availability to 
the pathogen (131). Interestingly, it has also been reported that Fpn is rapidly recruited to 
M. tuberculosis-containing phagosomes where it would presumably provide iron to the 
phagocytosed bacteria (132).   
 
 
1.5 Phagocytes 
Phagocytes play a key role in innate immunity owing to their role in nutritional 
immunity. However, phagocytic cells also utilize mechanisms other than nutritional 
immunity as part of their role in the innate immune system which are reviewed in the 
following sections. Phagocytes include cells like neutrophils, dendritic cells and 
macrophages – the latter of which are the focus of this project. 
 
1.5.1 Macrophages 
Macrophages are major effectors of both the innate and adaptive immune response. The 
designation of a macrophage as a professional phagocyte is central to its contribution to 
innate immunity. What differentiates professional phagocytes like macrophages, 
neutrophils, and dendritic cells, from other cells is their exceptional efficiency in 
performing phagocytosis and also their large repertoire of receptors that confer 
phagocytic function and recognition of many PAMPs (133, 134). During inflammation, 
monocytes, the precursor to macrophages, are recruited from the circulation via 
chemoattractants. For example, in response to pro-inflammatory cytokines many cells 
express CCL2 which is a ligand for CCR2 found on monocytes that mediates recruitment 
(135). Following chemoattraction, monocyte recruitment in response to inflammation is 
thought to follow a similar mechanism to that of leukocyte extravasation during which 
rolling adhesion, tight adhesion – both mediated by selectins and integrins – and finally 
tissue translocation, occur (136). Once they have entered the inflamed tissue, monocytes 
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differentiate into active macrophages with different phenotypes depending upon 
environmental cues they receive. Further, activated macrophages fit into a spectrum of 
macrophage polarization states. On one end of the spectrum is the M1 classically-
activated macrophage induced by PAMPs and inflammatory cytokines (IFN-") (137). At 
the other is the M2 alternatively-activated macrophage induced by anti-inflammatory 
cytokines like IL-10 and IL-4 (137). The M1 polarization state defines a pro-
inflammatory, antimicrobial macrophage whereas the M2 macrophage is anti-
inflammatory and is involved in tissue remodeling and repair (138, 139).  
Macrophages are constantly sampling the environment using cytoplasmic 
extensions called filopodia (140). Constant environmental surveillance coupled with 
expression of a wide variety of phagocytic receptors allows macrophages to detect many 
signals ranging from apoptotic cells to pathogens. Once these signals are detected, 
macrophages initiate internalization of the recognized particle in a process termed 
phagocytosis.  
 
1.5.2 Phagocytosis and phagocytic receptors 
Phagocytosis is a receptor-mediated process whereby professional phagocytes, such as 
macrophages, internalize large particles into a membrane-bound vesicle called the 
phagosome (141). As mentioned above, the expression of a vast array of receptors allows 
macrophages to recognize a multitude of ligands. For example, Fc" receptors recognize 
the Fc portion of human IgG found on opsonized particles or dectin-1, a PRR which 
recognizes fungal polysaccharides (142, 143). In contrast to these receptors is the integrin 
Mac-1 (also known as CR3 or #M$2) which acts very promiscuously and recognizes over 
30 ligands ranging from foreign particles to apoptotic corpses (141). It is important to 
note the fluidity of the plasma membrane of phagocytes which allows lateral movement 
of phagocytic receptors. Once a receptor is engaged, the now stationary ligand causes 
clustering of additional receptors which in turn activates the receptor to initiate 
phagocytosis (144). For example, Fc" receptor clustering brings cytosolic domains – the 
immunoreceptor tyrosine-based activation motif (ITAM) – in close proximity which 
allows for phosphorylation of the ITAM motif and initiation of downstream signaling 
(134, 141). 
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1.5.3 Phagosome maturation 
Once phagocytosis is initiated, the particle gets internalized into a membrane-bound 
compartment termed the phagosome. Newly formed phagosomes undergo a strictly 
ordered maturation process through membrane fusion events beginning with fusion of 
nascent phagosomes and early endosomes. This body, termed the early phagosome, 
further matures by sequential fusion with late endosomes and lysosomes, giving rise to 
late phagosomes and phagolysosomes, respectively (141).  
The stage of phagosome maturation is defined by the phagosomal membrane 
composition which is altered through vesicular traffic to and from the phagosome. In 
Figure 1 (modified from (5)), a schematic outlining molecular markers that biochemically 
define the stages of phagosome maturation is presented. To begin, in the forming 
phagosome both phosphatidylinositol-3,4,5-trisphosphate [PI(3,4,5)P3] and 
phosphatidylinositol 4-phosphate [PI(4)P] are enriched at the base of the phagocytic cup 
until the phagosome seals and membrane scission occurs (145, 146). After sealing, 
PI(3,4,5)P3 is rapidly lost. In addition, phagosomes become enriched with 
phosphatidylinositol-3-phosphate [PI(3)P], a marker of early phagosomes, and this is 
accompanied by loss of PI(4)P (147). Another marker of early phagosomes is the Rab 
GTPase Rab5. Rab GTPases are important effectors in a variety of processes inside the 
cell including the regulation of membrane trafficking and alternate between active-GTP 
bound and inactive GDP-bound states. Rab5 accumulates on the nascent phagosome and 
facilitates fusion with early endosomes (148). In addition, it is required for the acquisition 
of Vps34 which is a phosphatidylinositol-3-kinase (PI3K) responsible for the conversion 
of phosphotidylinositol (PI) to PI(3)P and is therefore crucial to phagosome maturation 
(147).  
Eventually the early phagosome transitions into a late stage phagosome upon 
acquisition of Rab7, the concomitant loss of Rab5, and regeneration of PI(4)P (146, 148). 
As well, the late phagosome is characterized by the acquisition of lysosome-associated  
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Figure 1. Phagosome maturation. The process of phagosome maturation involves a 
series of membrane fusion events that alter phagosome membrane composition and 
ultimately produce a mature, antimicrobial, phagolysosome. Shown are a number of 
membrane markers used to identify the phagosome stage such as PI(3)P, Rab5, Rab7, and 
LAMP1. Modified from (5).  
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membrane protein 1 (LAMP1). LAMP1 is an integral membrane protein found on late 
endosomes, lysosomes and fully mature phagosomes (149). The late endosome, as 
defined by the presence of LAMP1 and Rab7, then fuses with lysosomes to form the 
phagolysosome - the ultimate microbicidal compartment inside the cell. The 
phagolysosome can be defined biochemically by its markedly acidic pH and also by the 
presence of lysosomal hydrolases.  
 
1.5.4 Antimicrobial effectors of macrophages  
Phagosome maturation ultimately leads to the creation of a microbicidal organelle where 
killing is mediated through a number of mechanisms, namely: acidification, the use of 
degradative enzymes, reactive oxygen and nitrogen species, and nutrient limitation (5, 
150). Phagosome acidification begins early in phagosome maturation with accumulation 
of vacuolar ATPases (vATPases) that pump H+ ions into the phagosome lumen (151). 
Low pH maintenance is also aided by the reduced proton permeability of the phagosome 
membrane, effectively reducing “proton leak” (151). Acidification is necessary for 
maturation and aids in pathogen clearance by creating a harsh environment for bacteria to 
survive.  
In addition to acidification, lysosomal proteases are delivered to the phagosome 
and are active against phagocytosed bacteria. A prominent example is the cathepsin 
family of cysteine proteases that generally become active at lysosomal pH and promote 
killing of the bacteria (152, 153). To add to this already hostile environment, the 
macrophage also uses NADPH oxidase to produce reactive oxygen and nitrogen species 
that damage proteins, lipids and DNA (154).  Lastly, as already discussed in detail above, 
macrophages utilize nutritional immunity to augment the other antimicrobial effectors of 
the phagosome. By far the most extensively studied example is the NRAMP1 protein 
which is recruited to the phagosome and acts to extrude divalent cations from the lumen 
of the phagosome (75).  
 
1.5.5 Bacteria that manipulate phagocytosis  
Remarkably, despite numerous mechanisms employed to kill phagocytosed bacteria, 
many pathogens have evolved ways to survive inside macrophages. Some intracellular 
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pathogens like Yersinia pestis are capable of altering phagosome maturation by 
subverting acidification thereby effectively evading killing by macrophages (155). 
Similarly, the pathogen Klebsiella pneumonaie alters phagosome maturation, prevents 
delivery to the lysosome and thereby mediates survival within the macrophage (156). M. 
tuberculosis uses many mechanisms to halt phagosome maturation (157–159) and also 
prevents inflammasome activation to mediate survival within the macrophage (160). 
Bacterial toxins have also been used to escape the phagosome. This method is employed 
by L. monocytogenes which produces the toxin Listeriolysin O, a pore-forming toxin that 
disrupts the membrane of the phagosome to mediate escape into the macrophage 
cytoplasm (161).  
 
 
1.6 Endocytosis and endocytic protein trafficking 
Another important aspect to review for this study are endocytic protein trafficking 
pathways. Endocytosis is broad term encompassing several different pathways including 
phagocytosis and a slightly different process, receptor-mediated endocytosis. As already 
discussed, phagocytosis involves the receptor-mediated internalization of large particles 
such as apoptotic cells and microbes. Receptor-mediated endocytosis involves the 
selective uptake of specific molecules, such as Tfn or epidermal growth factor (EGF), 
bound to their cognate membrane-embedded receptors into a membrane bound 
compartment, or endosome (162). Endosomes undergo a similar maturation process as 
outlined for the phagosome in section 1.5.3.  This similarity highlights that despite 
differences in cargo and in initialization of internalization, internalized proteins 
ultimately join the endocytic protein trafficking network within the cell. However, while 
the final step in phagocytosis is always the destruction of the internalized cargo, during 
endocytosis some cargos have fates besides destruction. Both the final fate of trafficked 
cargo and the trafficking mediators involved define different trafficking pathways. The 
following briefly reviews indispensable mediators of protein trafficking, the Rab 
GTPases, and some fates of endocytosed cargo. 
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1.6.1 Rab GTPases 
Rab GTPases are important effectors of vesicular, and therefore protein trafficking (163). 
In humans, there are more than 60 identified Rabs that are localized to distinct 
intracellular membranes (164). Thereby, Rabs are important for defining the identity of 
an endocytic vesicle but also for regulating membrane traffic throughout the cell. Rab 
GTPases function as “molecular switches” in that they alternate between active-GTP 
bound and inactive GDP-bound states. This cycle is mediated by both GEFs (guanine 
nucleotide exchange factors) and GAPs (GTPase activating proteins). GEFs facilitate the 
exchange of GDP and GTP, while GAPs are important for catalysis of GTP hydrolysis.  
Molecular switching allows Rab proteins to regulate endosomal membrane trafficking 
mechanisms such as receptor recycling or receptor degradation.  
 
1.6.2 Recycling 
One important fate for endocytosed cargo is recycling back to the plasma membrane. 
TfnR is considered a prototypical recycled protein. When Tfn binds to TfnR, this 
complex is internalized via receptor-mediated endocytosis. As with the phagosome, the 
endosome begins to acidify resulting in the dissociation of ferric iron from Tfn, allowing 
iron to be transported to the cytoplasm (165). The apoTfn-TfnR complex is eventually 
recycled back to the plasma membrane via one of two routes: the fast or the slow 
recycling pathway (162). The fast route is mediated by the GTPase Rab4 and involves 
direct transport from the early endosome back to the plasma membrane (166). 
Alternatively, the slow route is mediated by Rab11 and involves sorting the complex into 
the perinuclear endocytic recycling compartment (ERC) from which the complex is 
recycled back to the plasma membrane (167). At the plasma membrane, the neutral pH 
decreases the affinity of TfnR for apo-Tfn resulting in release of apo-Tfn into the 
circulation. Because TfnR recycles through both pathways, it is often used as a tool to 
investigate the trafficking mechanism of other proteins. 
 
1.6.3 Degradation 
Not all endocytosed proteins end up being recycled. For instance, if a cell needs to stop 
signaling from a certain ligand the cell then degrades the ligand’s receptor. Such is the 
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case for the epidermal growth factor (EGF) and its receptor (EGFR) which is degraded 
via the formation of multivesicular bodies (MVBs) (168). Upon binding to EGF, the 
EGF-EGFR complex is endocytosed into clathrin-coated vesicles. The clathrin-coat is 
shed and this vesicle fuses with the early endosome. EGFR is then sorted into 
intraluminal vesicles (ILVs) which are invaginations of endosomal membrane into the 
lumen of the endosome (169). This sorting is mediated by the endosomal sorting complex 
required for transport (ESCRT) machinery. Endosomes containing ILVs are termed 
MVBs. Upon fusion of the MVB with the lysosome, any cargo contained within the ILVs 
is degraded (170).  As with recycling, Rab proteins mediate some aspects of the MVB 
pathway. For example, Rab7 is important for fusion of MVBs with lysosomes wherein 
RNA interference of Rab7 resulted in enlarged MVBs and almost complete inhibition of 
EGFR degradation (171).  
 
 
1.7 Project rationale and hypothesis 
Nutritional immunity is an important facet of innate immunity. During bacterial 
infection, macrophages are key mediators of the nutritional immune response, especially 
iron sequestration. Ferroportin is an iron-exporting protein found on the plasma 
membrane of macrophages that plays a role in nutritional immunity. While the 
mechanism and fate of hepcidin-induced Fpn degradation is characterized, this project is 
focused on the fate and trafficking mechanism exclusively of phagosomal Fpn during 
bacterial infection. More specifically, in the early stages of infection - before increased 
production of hepcidin occurs - what happens to Fpn during phagocytosis of bacteria? If 
the localization or function of Fpn was not altered in any way (Fig 2A), upon phagosome 
formation Fpn would remain on the phagosomal membrane (Fig 2B). Due to the 
orientation of Fpn in the membrane, this would ultimately lead to the transport of iron 
into the phagosomes and provision of phagocytosed bacteria with iron.  
I hypothesized that during phagocytosis, macrophages remove Fpn from the 
phagosomal membrane to prevent the extrusion of iron into the phagosome lumen. 
As depicted in Figure 2, several mechanisms employed by the macrophage could 
remove Fpn from the phagosome: i) Fpn may be retrieved from phagosomes and 
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trafficked back to the plasma membrane through recycling pathways akin to TfnR (172) 
(Fig 2E), ii) regions of the polypeptide in the phagosome lumen may be proteolytically 
degraded while it remains in the phagosomal membrane upon phagosome-lysosome 
fusion (Fig 2D), or iii) it may be degraded entirely in the phagosome lumen as part of a 
MVB akin to the EGFR (168) (Fig 2C). Lastly, it is possible that Fpn gets caught in the 
cytoskeletal network of the cell and is excluded from the phagosome altogether (Fig 2F), 
akin to CD45, a receptor-like protein tyrosine phosphatase (173). 
To test this hypothesis, I pursued three different objectives. 1) The first objective 
was to determine if Fpn is removed from the phagosome during phagocytosis using 
fluorescent fusion proteins and fluorescence microscopy. 2) The second objective was to 
determine if Fpn is removed from the phagosome via degradation using an inhibitor of 
cellular degradation mechanisms. 3) Lastly, I wanted to compare Fpn localization to 
known trafficking mediators within the cell to determine the trafficking mechanism of 
Fpn from the phagosome.  
The goal of this research is to advance our understanding of iron-restriction 
during bacterial infection and help provide a more complete understanding of host 
nutritional immune responses.   
  
  
25 
 
 
 
 
 
Figure 2. Postulated mechanisms of Fpn removal from the phagosome. (A) At rest, 
Fpn resides in the macrophage plasma membrane where it extrudes iron out of the cell. If 
Fpn is not modulated, after phagocytosis of a bacterium, Fpn would extrude iron into the 
phagosome lumen providing iron that could be used for microbial growth (B). In (C), Fpn 
is removed from the phagosome membrane and subsequently degraded via the formation 
of a MVB. Fpn may also remain on the phagosomal membrane and get proteolytically 
degraded after fusion with a lysosome (D) or it may be removed from the phagosome 
membrane and then be recycled back to the plasma membrane (E). Lastly, it is possible 
that Fpn gets trapped in the cytoskeletal network of the cell and is excluded from the 
phagosome altogether (F). 
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CHAPTER 2 – MATERIALS and METHODS 
 
2.1 Reagents  
Roswell Park Memorial Institute 1640 medium (RPMI) and fetal bovine serum (FBS) 
were from Wisent Inc (St. Bruno, QC, Canada). Paraformaldehyde 16% solution and #1 
thickness round cover glass slips (18mm diameter) were from Electron Microscopy 
Sciences (Hatfield, PA, USA). The Cell Proliferation Dye eFluor® 670 was from 
eBiosciences (San Diego, CA, USA). Both 3.14µm and 1.54µm silica beads were from 
Bangs Laboratories (Fishers, IN, USA). Lyophilized human IgG was from Sigma Aldrich 
(St. Louis, MS, USA). Rat anti-mouse LAMP-1 antibody (clone 1D4B) was deposited by 
J.T August to The Developmental Studies Hybridoma Bank at the University of Iowa 
(Iowa City, IA, USA). The pharmacological agents LY294002 and Concanamycin A 
were from Santa Cruz Biotechnology (Dallas, TX, USA). Fluorophore conjugated 
antibodies including goat anti-rat Cy3 and goat anti-human AlexaFluor® 647 were from 
Jackson Immunoresearch (West Grove, PA, USA). Lipofectamine! 3000 and 
Lysotracker! Red DND-99 were from Invitrogen (Mississauga, ON, Canada). Horse 
serum was from Sigma-Aldrich (St. Louis, MO, USA). All restriction enzymes were 
purchased from New England Biolabs (Ipswich, MA, USA).  
 
2.2 Bacterial strains, plasmids and culture conditions 
The bacterial strains and plasmids used in this study are summarized in Table 1. 
Methicillin-resistant S. aureus strain USA300, cured of its endogenous antibiotic 
resistance plasmid, was routinely cultured in Tryptic Soy broth (TSB) (Difco) at 37°C 
with shaking. When appropriate, S. aureus carrying the plasmid pAH9 was cultured in 
TSB in the presence of erythromycin at 3 µg/mL. Solid media were prepared with the 
addition of Bacto-agar (1.5% w/v). 
For cloning purposes, E. coli DH5α was cultured in LB broth with shaking or on 
LB agar (1.5% w/v) at 37°C. E. coli carrying the plasmid encoding Fpn-GFP (called 
pTF1) was grown at 30°C for 48h. Throughout this study, all E. coli strains carrying 
plasmids were cultured in media containing kanamycin (40 µg/mL). 
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Table 1. Bacterial strains and plasmids used in this study   
Strain or plasmid Description* Source / Reference 
Staphylococcus aureus  
USA300 USA300 LAC; MRSA cured of antibiotic resistance plasmid Laboratory stock 
   
Escherichia coli   
DH5ɑ 
F- ɸ80 dlacZΔM15 recA1 endA1 gyrA96 thi-1 
hsdR17(rK- mK+) supE44 relA1 deoR 
Δ(lacZYA-argF) U169 phoA λ- 
Laboratory stock 
   
Plasmids   
pAH9 S. aureus expressing mCherry from constitutive sarA promoter; Ery (174) 
pTF1 Mammalian expression vector encoding human Fpn fused to GFP; Kan This study 
mCherry-TfnR Mammalian expression vector encoding full length human TfnR fused to mCherry; Kan 
Michael Davidson 
Addgene#55144 
GFP-Rab4 Mammalian expression vector encoding Rab4 fused to GFP; Kan J. Brumell 
pTF2 Mammalian expression vector encoding human Fpn fused to mRuby; Kan This study 
TfnR-GFP Mammalian expression vector encoding TfnR fused to GFP; Kan S. Grinstein 
2xFYVE-RFP Mammalian expression vector encoding tandem FYVE domains fused to RFP; Kan S. Grinstein 
Rab5WT-mCherry Mammalian expression vector encoding Rab5 fused to mCherry; Kan R. Flannagan 
Rab5CA-mCherry 
Mammalian expression vector encoding 
constitutively active Rab5 (Q79L) fused to 
mCherry; Kan 
R. Flannagan 
p-mCherry-N1 Mammalian expression vector encoding soluble mCherry; Kan Clontech 
Rab7-mCherry Mammalian expression vector encoding Rab7 fused to mCherry; Kan (175) 
   
* Abbreviations: Ery and Kan indicate resistance to erythromycin and kanamycin 
respectively 
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The plasmid carrying the human Fpn (SLC40A1) gene (plasmid ID HsCD00335917) was 
purchased from the Harvard Plasmid Repository, Harvard University. To generate a 
plasmid encoding a Fpn-GFP fusion protein, the Fpn gene was PCR-amplified using the 
primers Fpn-F and Fpn-R (see Table 2 for primer sequence) and HsCD00335917 as a 
template. The amplicon was cloned into the mammalian GFP expression vector pEGFP-
N1 (Clontech) using EcoRI and AgeI restriction digest enzymes. The resulting Fpn-GFP 
expression vector, called pTF1, was identified by PCR and restriction analysis and 
confirmed by DNA sequencing at the London Regional Genomics Center (Robarts 
Research Institute, The University of Western Ontario). 
To generate a plasmid encoding a Fpn-mRuby fusion protein, Fpn-F and Fpn-R 
primers (Table 2) were used to PCR amplify the Fpn gene using pTF1 as the template. 
The amplicon was cloned into the mammalian mRuby expression vector mRuby-N1 (a 
gift from Michael Davidson, Addgene #54581) using EcoRI and AgeI restriction digest 
enzymes. The resulting vector, called pTF2, was confirmed by DNA sequencing.  
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Table 2. Oligonucleotides used for cloning 
Name Sequence* 
Fpn-F 5’ ATATATTGAATTCATGACCAGGGCGGGAGATCACAAC 3’  
Fpn-R 5’ ATATATTACCGGTGCAACAACAGATGTATTTGCTTGA 3’  
  
 
Used for cloning Fpn-GFP and Fpn-mRuby 
  * restriction sites are underlined 
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2.3 Mammalian cell culture and transfection 
The murine macrophage cell line RAW264.7 (RAW) was obtained from the American 
Type Culture Collection (ATCC, Manassas, VA, USA) and grown in RPMI 1640 
containing 10% FBS (v/v) at 37°C in a humidified atmosphere containing 5% CO2. 
Transfection was performed using Lipofectamine! 3000 as per the manufacturer’s 
protocol. Briefly, cells were seeded onto 18mm glass coverslips and incubated at 37°C 
with 5% CO2 overnight. In 125µL serum-free (SF) RPMI, 1µg of plasmid DNA was 
mixed with 2µL P300 reagent and 2µL Lipofectamine reagent, incubated for 5min, and 
then added dropwise to 1 well of a 12-well tissue culture plate. After at least 6h 
incubation with Lipofectamine/DNA mixture, cells were rinsed with SF-RPMI and 
incubated overnight with RPMI containing 10% FBS (v/v).   
 
2.4 Silica bead opsonization and phagocytosis 
Silica beads were opsonized with human IgG (1 mg/mL) for 1 hr in PBS at room 
temperature with constant shaking. After washing, IgG-coated beads were added to 
individual wells containing transfected RAW cells cultured on 18-mm glass coverslips 
and centrifuged for 1 min at 177 % g to promote synchronization of phagocytosis. Plates 
were then incubated at 37°C with 5% CO2 for various time-points and, at the appropriate 
time, cells were washed with PBS and fixed with 4% (v/v) paraformaldehyde (PFA) for 
20 min at room temperature.  
For all S. aureus infections, the bacteria were diluted in SF-RPMI and added to 
RAW cells at a multiplicity of infection of 30. Synchronization of engulfment and 
processing of cover slips after infection were performed as described above. 
 Detection of extracellular beads was performed by staining for 10 min with 
fluorophore-conjugated secondary anti-human antibodies (0.8 µg/mL in PBS) after 
fixation.  
 
2.5 Immunofluorescence staining of LAMP1 
RAW macrophages cultured on 18-mm glass coverslips and transfected with pTF1 were 
exposed to either IgG-coated silica beads or eFluor670-labelled S. aureus USA300. 
eFluor labelling of bacteria was done in saline containing 5 µM eFluor670 dye for 10 
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min. Bacteria were then washed with saline and re-suspended in SF-RPMI for infections. 
Phagocytic targets were added to macrophages as describe above and at 1 hr post-
addition the cells were fixed with 4% (v/v) PFA at room temperature for 20 min. Cells 
were then permeabilized using ice-cold methanol for 3 min. Permeabilized cells were 
blocked for at least 4 hr using horse serum. Next, the rat anti-mouse LAMP1 antibody 
(1:100 dilution of hybridoma supernatant) diluted in blocking buffer was incubated with 
the cells for at least 1 hr. Cells were then washed with PBS and the primary antibody 
detected using a goat anti-rat Cy3 antibody (750 µg/mL in blocking buffer). After 30 min 
with secondary antibody, cells were washed thoroughly with PBS and imaged using 
laser-scanning confocal microscopy.  
 
2.6 Concanamycin A treatment and Lysotracker! loading of macrophages  
For inhibition of vATPase-mediated acidification, RAW cells seeded on 18-mm glass 
coverslips and transfected with pTF1 were pre-treated with Concanamycin A (500 nM in 
SF-RPMI) for 30 min. IgG-coated beads were added to the cells, as described above, and 
then fixed 30 min after addition of beads. To demonstrate the effectiveness of 
Concanamycin A, untransfected RAW cells pre-treated with 500 nM Concanamycin A as 
above were incubated with Lysotracker! Red DND-99 at a final concentration of 250 
nM (diluted in SF-RPMI) for 10 min. Cells were then washed 3 times with SF-RPMI and 
immediately imaged live by wide-field microscopy.   
 
2.7 Wide-field fluorescence microscopy 
Wide-field fluorescence and differential interference contrast microscopy were performed 
on a Leica DMI6000B inverted microscope equipped with 40x (NA 1.3), 63x (NA 1.4) 
and 100x (NA 1.4) oil immersion PL-APO objectives, a Leica 100W Hg high-pressure 
light source and the Hammamatsu Orca Flash 4.0 and Photometrics Evolve 512 Delta 
EM-CCD cameras. This microscope is also outfitted with an objective warmer and an 
enclosed heated stage insert with CO2 reperfusion (Live Cell Instruments) for live cell 
fluorescence imaging. Images were acquired with 100x objective with the Photometrics 
EM-CCD camera using FITC, Cy3 and Cy5 filter settings as appropriate. All images 
  
32 
were obtained using wide-field fluorescence microscopy and subsequently deconvolved 
as described in section 2.9 unless otherwise indicated. 
 
2.8 Confocal microscopy 
Laser scanning confocal fluorescence microscopy was performed on a Leica TC5 SP5 
microscope comprised of a DMI6000 CS inverted microscope outfitted with argon/2 
(458, 476, 488, 514 nm), HeNe1 (543 nm), HeNe2 (633 nm) lasers and a PL-APO 63x oil 
immersion objective (NA 1.4). This microscope is equipped with triple dichroic TD 
488/543/633, a DD 488/543 dichroic and a tunable Acousto-Optical Beam Splitter for all 
laser lines. All confocal imaging was performed at the Robarts Research Institute 
Imaging Facility (The University of Western Ontario). 
 
2.9 Deconvolution and image analysis 
Z-stacks obtained using wide-field microscopy were subsequently deconvolved using the 
iterative 3D deconvolution application of the Leica Application Suite software prior to 
image analysis. All images were analyzed using ImageJ (National Institutes of Health, 
Bethesda, MD) and illustrations prepared using AutoDesk! Graphic.  
For quantification of Fpn-positive phagosomes a set of criteria was followed. 
First, only cells that expressed Fpn-GFP at the plasma membrane were analyzed as this 
was indicative that Fpn was being trafficked correctly throughout the cell. Further, only 
entirely intracellular phagocytic targets (the target did not label with anti-human 
secondary antibody, see section 2.4) were counted. For a phagosome to be considered 
Fpn-positive there had to be distinct signal defining the phagosome of similar intensity to 
the plasma membrane, it had to encircle at least 50% of the phagosome, and span more 
than 1 layer of the z-stack.  
 Co-localization analysis was performed using either the JACoP plugin or the Co-
loc2 plugin on ImageJ. JACoP was used to calculate Mander’s Coefficient and Pearson’s 
Coefficient for Figure 7 and Figure 11, respectively. To calculate Mander’s Coefficient: 
GFP-Rab4a was set to Ch1 and the corresponding mCherry was set to Ch2, the threshold 
was set manually and 3 slices per stack were used to calculate Mander’s Coefficient for 
each cell. M1 is the value presented as M2 is confounded by the plasma membrane 
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populations of mRuby-Fpn and mCherry-TfnR. Pearson’s Coefficient was calculated by 
setting Fpn-GFP to Ch1 and Rab5-mCherry to Ch2 and using the average of 3 slices per 
stack to calculate Pearson’s Coefficient for each cell.  
 Co-loc2 was used to calculate Pearson’s Coefficient for Figure 6 because JACoP 
does not have ROI selection capabilities. The Fpn-GFP channel was set to Ch1 and the 
mCherry-TfnR channel was set to Ch2, an ROI was selected in the GFP channel 
encircling the cytoplasm and excluding the plasma membrane of the cell. Pearson’s 
Coefficient was calculated using 1 slice per cell. 
 
2.10 Statistical analysis 
GraphPad Prism 7 software was used to perform statistical tests and generate graphs 
(GraphPad software, La Jolla, CA). Data was analyzed statistically using unpaired t-tests 
or two-way analysis of variance with either Tukey’s or Dunnet’s multiple comparisons 
test as indicated. Significance was set to p < 0.05.  
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CHAPTER 3 – RESULTS 
 
3.1 Fpn is removed from phagosomes harbouring S. aureus or IgG-coated beads 
!
Trafficking of Fpn during phagocytosis is not characterized and to rectify this I sought to 
determine if Fpn remains on the phagosome or if the protein is removed from the 
phagosome during maturation. To visualize Fpn trafficking within the phagocyte, I 
constructed a Fpn-GFP fusion protein as described in Chapter 2 and established that the 
Fpn-GFP fusion protein localizes to the plasma membrane as expected and does not 
perturb phagocytosis in RAW cells (see Appendix 1).  
RAW cells expressing Fpn-GFP were i) exposed to IgG-coated beads (Fig 3A, top 
row) or ii) infected with S. aureus USA300 carrying plasmid pAH9 (pAH9 expresses 
mCherry; see Table 1) (Fig 3A, bottom row) and fixed 5, 15, and 60 min post-addition of 
the phagocytic targets. All images were obtained using wide-field fluorescence 
microscopy and subsequently deconvolved unless otherwise indicated. The presence of 
Fpn-GFP on phagosomes containing staphylococci or IgG-coated beads was analyzed 
using the criteria outlined in section 2.9. Beads and bacteria that were not phagocytosed 
were labelled using a secondary antibody (magenta). Image analysis revealed that Fpn-
GFP was depleted from maturing phagosomes irrespective of phagocytic target and that 
by 60 min approximately 90% of phagosomes were Fpn-negative (Fig 3C). Interestingly, 
I failed to detect uptake of S. aureus 5 min post-infection, demonstrating important 
differences in the phagocytic efficiency of RAW macrophages when ingesting targets 
through Fc" receptors as opposed to other non-opsonic receptors (134).  
 To confirm the finding that Fpn is absent from late-stage phagosomes, using laser-
scanning confocal microscopy I compared Fpn-GFP localization to that of LAMP1, a 
biochemical marker of late phagosomes and phagolysosomes (149), at 60 min post-
phagocytosis. RAW cells expressing Fpn-GFP were exposed to IgG-coated beads (Fig 
3B, top panel) or infected with eFluor670-labelled S. aureus USA300 (Fig 3B, bottom 
panel) and 1 hr after addition of targets, the cells were immunostained for LAMP1. 
Quantitation of the percentage of phagosomes showing LAMP1 accumulation revealed 
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that 75% or more of LAMP1-positive phagosomes are devoid of Fpn irrespective of the 
phagosomal cargo (Fig 3D).  
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Figure 3. Fpn is depleted from the phagosome as it matures. (A) RAW macrophages 
expressing Fpn-GFP (green) were exposed to either IgG-coated beads (top row) or S. 
aureus pAH9 (red; bottom row) and fixed 5, 15, and 60 min post-addition of phagocytic 
targets. Extracellular beads and bacteria at each time point were fluorescently labelled 
(magenta). S. aureus was inefficiently phagocytosed at 5 min despite numerous cocci 
bound to phagocyte surfaces (not shown). A hollow arrow denotes a Fpn-positive 
phagosome and filled arrows indicate Fpn-negative phagosomes. Bar equals 10µm. (B) 
Confocal sections of RAW cells expressing Fpn-GFP exposed to either IgG-coated beads 
(top panel) or infected with eFluor670-labelled USA300 (bottom panel). Fluorescence 
micrographs depict the distribution of endogenous LAMP1 (red) 1 hr after the addition of 
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phagocytic targets. White arrowhead points to a bead-containing phagosome. Bar equals 
10µm. (C) Quantification of the fraction of Fpn-positive phagosomes at the indicated 
time points is presented. Data are the mean ± SEM from &92 phagosomes from at least 3 
independent experiments. Statistical significance was determined using two-way 
ANOVA with Tukey’s multiple comparisons test, where *p < 0.05, **p < 0.01, and n.s is 
not significant. (D) Quantification of the fraction of phagosomes that are LAMP1-
positive and Fpn-negative. The graph represents the mean ± SEM from &129 LAMP1-
positive phagosomes derived from 3 independent experiments. Statistical significance 
was determined using an unpaired t-test, where n.s is not significant. 
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3.2 Selective exclusion of Fpn from LAMP1-positive phagosomes 
!
While comparing Fpn-GFP and LAMP1 localization in USA300-infected RAW cells, I 
observed that non-phagosomal, discrete GFP-positive puncta were localized throughout 
the cytosol of Fpn-GFP expressing cells, and that these puncta co-localized with LAMP1. 
Interestingly, phagocytosed cocci resided in LAMP1-positive but Fpn-GFP-negative 
phagosomes at this same time point. Implicit in this observation is that not all LAMP1 
positive compartments are created equally and that there is a mechanism to selectively 
exclude Fpn from LAMP1 containing phagosomes while directing Fpn to other LAMP1 
positive compartments that are not phagosomes (Fig 4).  
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Figure 4. Selective exclusion of Fpn from LAMP1-positive phagosomes. Confocal 
sections depicting the distribution of endogenous LAMP1 (red) in RAW cells expressing 
Fpn-GFP (green) is shown. RAW macrophages were incubated with eFluor670-labelled 
S. aureus USA300 for 60 min and then immunostained. The insets depict the absence of 
GFP from LAMP1-positive phagosomes (bottom) and co-localization of Fpn-GFP puncta 
with LAMP1 (top). Bar equals 10µm. 
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3.3 Inhibition of acidification does not prevent Fpn removal from the phagosome 
 
As Fpn is present on some early phagosomes (Fig 3A, hollow arrow), I concluded that 
Fpn exclusion from the phagosome is unlikely (Fig 2F). Multivesicular body formation 
and phagosome-lysosome fusion occur in the late stages of phagosome maturation and 
because Fpn is removed early in the phagosome maturation process, I postulated that it is 
unlikely that Fpn removal is occurring via these late-stage processes. Degradation of 
phagocytic cargo in these processes is, in part, mediated by the acidification of the 
phagosome and so I sought to test this postulation by inhibiting acidification using the 
vATPase inhibitor Concanamycin A (CcA) (176). RAW cells were pre-treated with a 
vehicle control (DMSO) or 500 nM CcA for 30 min in SF-RPMI. To confirm inhibition 
of acidification, after 30 min treatment, cells were stained with the acidotropic probe 
Lysotracker! Red DND-99 and imaged live using identical acquisition parameters for 
each condition (Fig 5A). In vehicle control treated cells, regions of Lysotracker! 
accumulation were present indicating acidic vacuoles. In comparison, in cells treated with 
CcA, Lysotracker! accumulation was completely ablated demonstrating the absence of 
acidic vacuoles and the efficacy of CcA treatment. After confirming CcA treatment was 
working, to test if acidification mediated Fpn removal, RAW cells expressing Fpn-GFP 
were pre-treated with vehicle control or 500 nM CcA for 30 min in SF-RPMI. At this 
point, IgG-coated beads were added, cells were maintained in the presence of 500 nM 
CcA, and allowed to phagocytose for 30 min before fixation (Fig 5B). Quantification 
revealed that there was no significant difference in the fraction of Fpn-positive 
phagosomes in CcA treated cells compared to control (Fig 5C). This finding supports the 
postulation that Fpn removal from the phagosome likely occurs through a mechanism 
other than MVB-mediated or lysosomal degradation.  
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Figure 5. Phagosomal loss of Fpn is not altered upon inhibition of acidification. (A) 
RAW macrophages pre-treated with a vehicle control (veh) or 500 nM CcA for 30 min 
were exposed to 250 nM Lysotracker! Red for 10 min, washed, and imaged live. Images 
were taken using identical acquisition parameters between conditions. Insets depict 
corresponding differential interference contrast images. Bar equals 20µm. (B) RAW cells 
expressing Fpn-GFP were treated as above except after 30 min pre-treatment, IgG-coated 
beads were added and cells allowed to phagocytose for 30 min. Arrows in insets indicate 
Fpn-negative phagosomes while the arrowhead indicates a Fpn-positive phagosome. 
Extracellular beads were labelled fluorescently (blue). Bar equals 20µm. (C) 
Quantification of the fraction of Fpn-positive phagosomes for the indicated treatment. 
Data are the mean ± SEM from &95 phagosomes from at least 3 independent 
experiments. Statistical significance was determined using an unpaired t-test, where n.s is 
not significant.  
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3.4 Fpn and TfnR do not co-localize in the cytoplasm of macrophages 
!
Since Fpn removal from the phagosome occurs early during phagosome maturation (Fig 
3C) I next sought to investigate whether Fpn is removed and recycled back to the plasma 
membrane. 
To investigate this possibility, I compared the distribution of Fpn throughout the 
cell to that of TfnR - a prototypical marker of the recycling pathway (172). RAW 
macrophages were co-transfected with plasmids encoding Fpn-GFP and mCherry-TfnR, 
IgG-coated beads were added to initiate phagocytosis, and the cells were fixed 15 min 
after addition (Fig 6A). Outside beads were labelled using a secondary antibody (blue). 
Image analysis software was used to calculate the degree of co-localization between Fpn 
and TfnR. If the proteins use the same trafficking mechanism, overlap between the two 
signals should occur. However, calculating Pearson’s coefficient on the entire cell would 
likely indicate some degree of co-localization since both Fpn and TfnR localize to the 
plasma membrane. To overcome this confounding factor, a region of interest (ROI) was 
drawn around the entire cytoplasm of the cell, excluding only the plasma membrane, and 
Pearson’s coefficient was calculated using this ROI. Pearson’s co-localization coefficient 
is a value that ranges from -1 to +1, where -1 is perfect negative-correlation, 0 is no 
correlation, and +1 is perfect correlation (177–179). The extreme values of Pearson’s 
coefficient are easy to interpret while intermediate values are less conclusive.  Knowing 
this, based on the ROI selected to exclude the plasma membrane from calculations, Fpn 
and TfnR did not demonstrate a high degree of co-localization on membranes inside of 
the macrophage (i.e. membranes other than the plasma membrane) (Fig 6B). These data 
indicate that Fpn and TfnR may use different trafficking mechanisms.  
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Figure 6. Fpn and TfnR do not co-localize in the cytoplasm of macrophages. (A) 
RAW macrophages co-expressing Fpn-GFP (green) and mCherry-TfnR (red) were 
exposed to IgG-coated beads and fixed 15 min post-addition of beads. Extracellular beads 
were labelled fluorescently (blue). Insets demonstrate regions within the cell where little 
overlap between signals occurs. Bar equals 20µm. (B) Graph depicts Pearson’s co-
localization coefficient from an ROI containing only the cytoplasm of each cell. Data are 
the mean ± SD from 23 cells from 3 independent experiments.      
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3.5 TfnR co-localizes with Rab4 while Fpn does not 
 
To further investigate the possibility that Fpn is recycled I wanted to determine if Rab4 is 
involved in Fpn removal from the phagosome. Rab4 is a GTPase that localizes to early 
endosomes and is involved in the fast recycling pathway (166, 180). The fast recycling 
pathway recycles cargo like TfnR from the early endosome back to the plasma 
membrane, bypassing the endocytic recycling compartment (162). RAW cells were co-
transfected with plasmids encoding either GFP-Rab4 and mCherry-TfnR (Fig 7A) or 
GFP-Rab4 and Fpn-mRuby (Fig 7B), exposed to IgG-coated beads and fixed 15 min after 
initiation of phagocytosis. Beads were added to initiate the phagocytic process. Co-
localization was measured using Mander’s co-localization co-efficient. Mander’s co-
localization coefficient consists of two different values that both range from 0 to +1. 
They represent the fraction of pixels in one channel (ie. red channel) that have a 
corresponding pixel above a set threshold in a second channel (ie. green channel). The 
converse for the second coefficient is true (ie. the fraction of pixels in the green channel 
that have a corresponding pixel in the red channel) (177, 178).  As mentioned above, 
Rab4 mediates the recycling of TfnR and thus I expected to observe co-localization 
between Rab4 and TfnR (Fig 7C). If Fpn trafficking is mediated by Rab4 I would expect 
a similar degree of co-localization between Rab4 and Fpn. However, Mander’s 
coefficient for Fpn and Rab4 is significantly lower than that for TfnR and Rab4 (Fig 7C). 
This evidence suggests that Rab4 is not involved in the trafficking of Fpn and supports 
previous evidence (Fig 6) that Fpn is trafficked via a different mechanism than TfnR. 
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Figure 7. TfnR, but not Fpn, co-localizes with Rab4.  (A) RAW macrophages 
expressing mCherry-TfnR (red) and GFP-Rab4 (green) were exposed to IgG-coated 
beads and fixed 15 min post-addition of phagocytic targets. Extracellular beads were 
labelled fluorescently (blue). Filled arrows denote Rab4 features that co-localize with 
TfnR puncta. Bar equals 20µm. (B) RAW cells expressing Fpn-mRuby (red) and GFP-
Rab4 (green) were exposed to IgG-coated beads and fixed 15 min after addition of beads. 
Extracellular beads were labelled fluorescently (blue). Hollow arrows denote Rab4 
features that do not co-localize with Fpn puncta. Bar equals 20µm. (C) Graph depicts 
Mander’s coefficient for co-localization of GFP-Rab4 with either Fpn-mRuby or 
mCherry-TfnR. Data are the mean ± SEM from ≥17 cells from at least 4 independent 
experiments. Statistical significance was determined using an unpaired t-test, where * p < 
0.05.  
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3.6 Early PI(3)P-positive phagosomes show more Fpn depletion than TfnR depletion 
 
Thus far, I have demonstrated that Fpn is removed from the phagosome via a mechanism 
that likely differs from the mechanism by which TfnR is removed from phagosomes. 
Based on this I wanted to further elucidate the kinetics of Fpn removal from the 
phagosome using different markers of the phagosome maturation process. RAW cells 
were transfected with plasmids encoding 2xFYVE-RFP and either Fpn-GFP or TfnR-
GFP. 2xFYVE is a lipid biosensor of PI(3)P, a marker of early phagosomes (Fig 1) (147). 
The transfected cells were then exposed to IgG-opsonized beads and fixed 10 min post-
initiation of phagocytosis (Fig. 8A). Early phagosomes, as indicated by the presence of 
2xFYVE, were found to be largely (>95%) Fpn-negative (Fig 8B). In contrast, 
significantly more PI(3)P-positive, early phagosomes were TfnR-positive (70%) (p < 
0.01) (Fig 8B). This marked difference in the phagosomal distribution of Fpn and TfnR 
again indicates that Fpn is removed from the phagosome through a different mechanism 
than TfnR.   
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Figure 8. Early PI(3)P positive phagosomes show more Fpn depletion than TfnR 
depletion.  (A) Confocal sections depicting RAW macrophages expressing Fpn-GFP (top 
row) or TfnR-GFP (bottom row) (green) and the PI(3)P biosensor 2xFYVE-RFP (red) 
that were allowed to phagocytose IgG-coated beads for 10 min. After fixation, the 
presence of phagosomal Fpn-GFP, TfnR-GFP, and 2xFYVE-RFP was analyzed. Arrows 
indicate a TfnR and 2xFYVE-positive phagosome while arrowheads indicate a Fpn-
negative but 2xFYVE-positive phagosome. Bar equals 10µm. (B) The graph depicts the 
fraction of 2xFYVE-positive phagosomes that are positive for either Fpn- or TfnR-GFP. 
The data represents the mean ± SD derived from ≥ 56 phagosomes from at least 3 
independent experiments. Statistical significance was determined using an unpaired t-test, 
where **p < 0.01.  
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3.7 The PI3K inhibitor LY294002 alters cellular distribution of TfnR but not Fpn  
 
The accumulation of PI(3)P on the early phagosome is due to the acquisition of Vps34, 
the Class III PI3K responsible for the catalysis of PI to PI(3)P (147). Based on this role of 
PI3K, I wanted to determine if Fpn trafficking throughout the cell is dependent upon 
PI3K. To do this I used the PI3K inhibitor LY294002 (181). Observation of the 
distribution of either Fpn or TfnR throughout the cell revealed that while the distribution 
of TfnR was altered upon exposure to LY294002 (Fig 9A) the distribution of Fpn was 
unaffected (Fig 9B). More specifically, in vehicle control treated cells TfnR was found 
largely at the plasma membrane (Fig 9A, arrowheads). As has been reported previously 
(172), upon treatment with 100 µM LY294002 in TfnR-GFP expressing cells enlarged 
endosomal vesicles (Fig 9A, filled arrows) or a large perinuclear accumulation of TfnR 
(Fig 9A, hollow arrows) was observed thus demonstrating the efficacy of LY294002-
treatment in altering protein trafficking. Interestingly, no observable change in 
distribution of Fpn occurred upon PI3K inhibition (Fig 9B). This finding provides 
evidence that LY294002 treatment is functional, provides further evidence that Fpn and 
TfnR are trafficking through different mechanisms, and alludes that PI3K activity is not 
essential for Fpn trafficking. 
 
  
  
49 
 
 
 
 
Figure 9. The cellular distribution of TfnR but not Fpn is altered upon exposure to a 
PI3K inhibitor. RAW cells transfected with either (A) TfnR-GFP or (B) Fpn-GFP were 
pre-treated with 100 µM LY294002 or with a vehicle control (veh) for 30 min. IgG-
coated beads were then added to initiate phagocytosis and cells were fixed 30 min after 
addition. Extracellular beads were labelled fluorescently (blue). Bar equals 20µm.  In (A), 
arrowheads highlight the presence of TfnR primarily at the plasma membrane in vehicle 
control treated cells. Filled arrows emphasize enlarged TfnR-containing endosomal 
vesicles and hollow arrows indicate the perinuclear accumulation of TfnR in LY294002- 
treated cells.  
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3.8 PI3K-independent removal of Fpn from the phagosome  
 
Based on the findings that Fpn is removed from the phagosome before PI(3)P 
accumulates (Fig 8) and that Fpn trafficking is not altered upon PI3K inhibition I next  
wanted to look expressly at phagosomal populations of Fpn. More specifically, I wanted 
to determine if Fpn removal from the phagosome is dependent upon the activity of PI3K, 
which precedes PI(3)P accumulation on the phagosome. To do this, I again used the PI3K 
inhibitor LY294002 (181). I expected that if Fpn removal is dependent on PI3K, upon 
PI3K inhibition Fpn removal from the phagosomal membrane would be delayed. RAW 
cells transfected with Fpn-GFP and 2xFYVE-RFP were pre-treated with 100 µM 
LY294002 for 10 min before addition of IgG-coated beads. Beads of 1.5µm in size were 
used because PI3K inhibition has been shown to only hinder phagocytosis of large targets 
(>5µm) (182).  Interestingly comparison of the fraction of Fpn-positive phagosomes in 
treated versus untreated macrophages yielded no difference between both conditions (Fig 
10). The absence of 2xFYVE-RFP-positive phagosomes in LY294002 treated cells 
versus vehicle control indicates that the LY294002 treatment was effective and blocked 
PI(3)P accumulation on the phagosome. This finding indicates that Fpn removal from the 
phagosome occurs independently of PI3K activity. Moreover, as MVB formation is 
PI(3)P-dependent (183) and inhibition of Vps34 does not alter Fpn removal, it stands to 
reason that MVB formation is not a major contributor to loss of Fpn from the phagosomal 
membrane.     
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Figure 10. Fpn removal from the phagosome occurs independently of PI3K. (A) 
RAW cells expressing the PI(3)P-biosensor 2xFYVE-RFP (red) and Fpn-GFP (green) 
were pre-treated with DMSO (vehicle control) or 100 µM LY294002 (PI3K inhibitor) for 
10 min. IgG-coated beads were added for 10 min before fixing and the fraction of 
2xFYVE-RFP- and Fpn-GFP-positive phagosomes were quantified. Beads that were not 
phagocytosed are labelled in blue. Arrowheads indicate Fpn-negative phagosomes while 
arrows indicate Fpn-positive phagosomes. Bar equals 20µm.  (B) Graph depicts the 
fraction of phagosomes positive for 2xFYVE-RFP or Fpn-GFP from either vehicle 
control or LY294002 treated cells. The data represent the mean ± SEM from ≥ 100 
phagosomes from 3 independent experiments. Statistical significance was determined 
using unpaired t-tests, where ***p < 0.001. 
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3.9 Fpn co-localizes with Rab5 during the early stages of phagosome maturation  
 
Because Fpn removal from the phagosome membrane occurs independently of PI3K (Fig 
10), I next investigated earlier events in the phagosomal maturation process by observing 
Rab5. Rab5 is a GTPase that is recruited to the nascent phagosome and is necessary for 
the recruitment of the PI3K Vps34 (184). RAW cells were co-transfected with plasmids 
encoding Fpn-GFP and Rab5WT-mCherry, exposed to IgG-coated beads and fixed 5, 9, 
and 15 min after initiation of phagocytosis (Fig 11A). Quantification revealed that 
approximately 75% of Rab5-containing phagosomes also contained Fpn at all three time 
points (Fig 11B). In addition, co-localization was observed between non-phagosomal 
Fpn-GFP puncta and Rab5WT-mCherry features in many cells (Fig 11A, arrowheads). 
This observation was confirmed using Pearson’s coefficient which indicates that indeed 
these fluorescent proteins partially co-localize (Fig 11C). Due to the partial co-
localization, it is conceivable that Rab5 could influence Fpn trafficking.  
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Figure 11. Fpn co-localizes with Rab5 during the early stages of phagosome 
maturation. (A) RAW cells were co-transfected with plasmids encoding Rab5WT-
mCherry (red) and Fpn-GFP (green) and fixed 5, 9, and 15 min after addition of IgG-
coated beads. Outside beads were labelled fluorescently (blue). Insets highlight Rab5-
positive and Fpn-positive phagosomes. Arrowheads indicate non-phagosomal Rab5 
features that are also Fpn-positive. Bar equals 10µm. (B) Graph depicts the fraction of 
Rab5-positive phagosomes that also contain Fpn at the indicated time point. Data are the 
mean ± SD from ≥ 32 cells, ≥ 47 Rab5-positive phagosomes from 3 independent 
experiments. (C) Graph depicts Pearson’s co-localization coefficient for Rab5WT-
mCherry- and Fpn-GFP-expressing cells. Data are the mean ± SD from 17 cells from 2 
independent experiments.  
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3.10 Fpn removal is temporarily delayed in cells expressing constitutively active 
Rab5  
 
Due to the co-localization between Fpn and Rab5, I next sought to determine whether 
Rab5 plays a functional role in the removal of Fpn from the phagosome. To do this, 
RAW cells were co-transfected with plasmids encoding Fpn-GFP and either Rab5WT-
mCherry (Fig 12B), Rab5CA-mCherry (Fig 12C), or a soluble mCherry protein as a 
negative control (Fig 12A). Constitutively active (CA) Rab proteins are mutants that are 
locked in the GTP-bound, active state. Soluble mCherry (p-mCherryN1) was used as a 
control to demonstrate that expression of CA Rab5 and not mCherry alone alters Fpn 
trafficking. IgG-coated beads were added and the cells were fixed 9, 15, 30, 45, and 60 
min after addition. The fraction of Fpn-positive phagosomes within each co-transfected 
cell was quantified (Fig 12D). At 9 min, all three states had similar proportions of Fpn-
positive phagosomes. However, at both 15 and 30 min there was significant increase in 
the fraction of Fpn-positive phagosomes in CA Rab5 expressing cells compared to the 
soluble mCherry control (p < 0.05) but this difference was lost by 45 min. This may be 
because the endogenously active Rab5 can overcome the effects of the transfected CA 
Rab5. These data, combined with the Rab5/Fpn co-localization data (Fig 11), suggest that 
Rab5 could play a functional role in the removal of Fpn from the phagosome.  
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Figure 12. Fpn removal is temporarily delayed in cells expressing a constitutively 
active Rab5.  (A) RAW cells were co-transfected with plasmids encoding soluble 
mCherry (p-mCherryN1; red) and Fpn-GFP (green) and were fixed 9, 15, 30, 45, and 60 
min after addition of IgG-coated beads. Outside beads were labelled fluorescently (blue). 
Asterisks (*) highlight Fpn-positive phagosomes.  (B) Same as (A) but cells were co-
transfected with Rab5WT-mCherry (red) and Fpn-GFP (green). (C) Same as (A) but cells 
were co-transfected with Rab5CA-mCherry (red) and Fpn-GFP (green). (D) Graph 
depicts fraction of Fpn-positive phagosomes in cells co-transfected with the indicated 
plasmids.  Data are the mean ± SEM from ≥ 17 cells, ≥ 88 phagosomes from at least 2 
independent experiments. Statistical significance was determined relative to control cells 
expressing p-mCherryN1 using two-way ANOVA with Dunnet’s multiple comparisons 
test, where *p < 0.05. Bar equals 10µm.  
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3.11 Fpn is present on some Rab7-containing phagosomes 
 
I next analyzed Rab7-mCherry expressing cells for the presence of Fpn-positive 
phagosomes. Rab7 is a GTPase that is recruited to the phagosome after Rab5 
accumulation and is a marker of late stage phagosomes (148) (Fig 1). This comparison 
was performed to demonstrate that it is specifically the over-expression of Rab5 and not 
simply the over-expression of any Rab protein that is causing the temporary retention of 
Fpn on the phagosome. To do this, RAW cells expressing Fpn-GFP and Rab7-mCherry 
were exposed to IgG-coated beads and fixed 15, 30, 45, and 60 min post-addition of 
phagocytic targets (Fig 13A). I then quantified the fraction of Fpn-positive phagosomes 
in Rab7-mCherry expressing cells, regardless of Rab7 presence on the phagosome (Fig 
13C). This analysis revealed no difference in the fraction of Fpn-positive phagosomes 
between Rab7 and soluble mCherry expressing cells providing further evidence that Fpn 
retention on the phagosome is a Rab5-specific event.  
 While performing this analysis, I also wanted to determine the degree of Fpn and 
Rab7 co-localization on the phagosome. Image analysis revealed that about 30% of 
phagosomes positive for Rab7 also contained Fpn (Fig 13B). This finding is surprising as 
analysis of early phagosomes demarcated by PI(3)P found that the majority of PI(3)P-
positive phagosomes were Fpn-negative (Fig 8).  
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Figure 13. Fpn is present on some Rab7-containing phagosomes. (A) RAW cells were 
co-transfected with plasmids encoding Rab7-mCherry (red) and Fpn-GFP (green) and 
were fixed 15, 30, 45, and 60 min after addition of IgG-coated beads. Outside beads were 
labelled fluorescently (blue). Insets highlight either Rab7-positive and Fpn-positive 
phagosomes (*) or Rab7-positive and Fpn-negative phagosomes. Bar equals 10µm. (B) 
Graph depicts the fraction of Rab7-positive phagosomes that also contain Fpn at the 
indicated time point. Data are the mean ± SD from ≥ 20 cells, ≥ 100 Rab7-positive 
phagosomes from 3 independent experiments. (C) Graph depicts fraction of Fpn-positive 
phagosomes in cells transfected with either p-mCherryN1 or Rab7-mCherry. Data are the 
mean ± SD from ≥ 17 cells, ≥ 70 phagosomes from at least 2 independent experiments.  
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CHAPTER 4 – DISCUSSION and FUTURE DIRECTIONS 
 
Iron is an essential nutrient required by virtually all forms of life and its acquisition and 
sequestration are important aspects of bacterial pathogenesis and host innate immunity, 
respectively. Collectively, the various mechanisms used to sequester nutrients and restrict 
access of essential metals like iron to pathogens is termed nutritional immunity (4). Host 
cells have both iron scavenging proteins and iron transporting proteins that together 
render iron inaccessible to invading microbes.  
Because iron is an essential nutrient for the host it follows that maintaining iron at 
homeostatic levels is also critical. Pivotal to iron homeostasis, Fpn is an iron transporting 
protein found in the plasma membrane of macrophages that pumps iron from the 
cytoplasm to the extracellular environment of the macrophage. The function of Fpn is 
modulated by hepcidin, a hormone produced by the liver. In response to inflammation, 
iron overload, or infection, hepcidin is produced and binds directly to Fpn, resulting in its 
endocytosis and ultimately its degradation (38, 124, 185); the net effect of this process is 
to reduce the pool of extracellular, or ‘labile’, iron available to invading pathogens. In 
contrast, in bacterially infected cells an increase of Fpn mRNA is observed leading to 
increased expression of Fpn at the plasma membrane (129–131). The net effect of this 
occurrence is increased iron export from the cell thereby limiting iron access to 
intracellular pathogens (131, 186). However, in infected macrophages that have i) not 
been exposed to hepcidin or that have ii) increased Fpn expression at the membrane, it is 
possible that after phagosome formation Fpn may reside on the phagosomal membrane. 
This is because upon phagosome formation the composition of nascent phagosomes 
largely resembles the composition of bulk plasma membrane. So, due to the orientation of 
Fpn, Fpn residing on the phagosome would transport iron into the pathogen-containing 
phagosomal compartment, potentially aiding the replicative capacity of the ingested 
microbes (Fig 2B). 
To this end, I sought to investigate what happens to Fpn in the early stages of 
infection before hepcidin production is increased using a model of phagocytosis in which 
Fpn is over-expressed at the membrane. This model presumably replicates the net effect 
of increased Fpn expression in response to infection. My findings suggest that Fpn is lost 
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from the phagosomal membrane during early stages of phagosome maturation thus 
supporting the hypothesis that the host removes Fpn from the phagosome to prevent 
phagocytosed bacteria from obtaining iron.  
At the outset of this study, four mechanisms of Fpn removal from the phagosome 
were postulated. As shown in Figure 2, I proposed that: i) Fpn may be recycled back to 
the plasma membrane (Fig 2E), ii) it may be proteolytically degraded while residing in 
the phagosomal membrane (Fig 2D), iii) Fpn may be degraded in the lumen of the 
phagosome as part of a MVB (Fig 2C), or iv) Fpn may be excluded from the phagosomal 
membrane altogether (Fig 2F).  
While the composition of nascent phagosomes generally resembles that of the 
plasma membrane, selective exclusion of certain membrane-associated proteins, like the 
tyrosine phosphatase CD45, from the phagosome has been described (187). Since Fpn-
positive phagosomes were observed throughout the study, recall the large fraction of 
early Rab5-containing phagosomes that are also Fpn-positive (Fig 11), I concluded that 
Fpn is not excluded from the phagosome.   
Despite the presence of Fpn on the early phagosome, I found that Fpn was 
ultimately eliminated from the phagosomal membrane. More specifically it was removed 
early during phagosome maturation and is gone by phagolysosomal formation for both 
phagosomes containing IgG-opsonized beads or S. aureus (Fig 3). This finding is in 
contrast with a previous finding that 2 h post-infection, phagosomes containing M. 
tuberculosis are Fpn-positive (132). This discrepancy may be attributed to the fact that M. 
tuberculosis perturbs phagosome maturation and the trafficking of endomembranes (157–
159).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
My findings demonstrate that inhibition of phagosomal acidification had no effect 
on Fpn removal from the phagosome (Fig 5) suggesting Fpn is not removed from the 
phagosome through a degradative mechanism. By pharmacologically inhibiting 
phagosomal acidification, phagosome maturation and all the degradative mediators 
therein – namely phagosome-lysosome fusion, delivery of lysosomal proteases, activation 
of proteases – are effectively halted (188, 189). A conceptually similar experiment 
utilized pharmacological agents to inhibit endosomal acidification to investigate EGFR 
degradation, the prototypical protein degraded via MVB formation. In this case, 
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inhibition of the vATPase using Bafilomycin A (functionally similar to CcA) prevented 
EGFR degradation (190). Notably, this study was investigating endosomal EGFR and not 
phagosomal EGFR specifically. So, while it provides precedence for using 
pharmacological agents to investigate protein degradation, it is important to note that 
endosomes and phagosomes are distinct organelles and differences are not uncommon. 
Nevertheless, the finding that inhibition of phagosomal acidification did not result in Fpn 
retention on the phagosome suggests that removal of Fpn from the phagosome does not 
occur through lysosomal-mediated degradation.  
Further evidence to support the notion that Fpn removal from the phagosome does 
not occur through lysosomal-mediated degradation is that Fpn is lost from the phagosome 
during early stages of maturation when phagosomes are demarcated by PI(3)P (Fig 8). 
Therefore, it is unlikely that Fpn remains on the phagosomal membrane long enough for 
phago-lysosomal fusion to occur. The finding that late stage LAMP1-containing 
phagosomes do not contain Fpn further supports this presumption (Fig 3 BD). It should 
be noted that the absence of Fpn on mature LAMP1-positive phagosomes is not due to 
acidification-meditated quenching of GFP signal. The pTF1 plasmid used throughout this 
study encodes GFP fused to the C terminus of Fpn and both termini of Fpn are 
intracellular. This indicates that upon phagosome formation, both termini would remain 
cytosolic and the GFP fluorescence would not be sensitive to phagosomal acidification. 
Further, upon fixation, pH gradients across membranes are lost, therefore if the GFP 
signal was quenched in an acidic compartment, GFP would still be detected in fixed 
samples if the chromophore of the fluorescence protein is intact. Therefore, the absence 
of GFP signal on the LAMP1-positive phagosome is due to absence of Fpn and not 
merely a loss of GFP fluorescence. 
At the outset of this study it was also proposed that Fpn may be removed from the 
phagosome by formation of a MVB. Some receptors in the phagosomal membrane get 
sorted into MVBs for subsequent degradation upon lysosome fusion (191). One example 
is the membrane receptor Fc"RIIA which is ubiquitinated, sorted into a MVB, and then 
degraded (192). Formation of MVBs requires PI3K activity (193) to recruit Hrs, a PI(3)P 
effector protein important in sorting of ubiquitinated proteins (194). My data 
demonstrating that Fpn is removed from the phagosome even when PI3K is inhibited (Fig 
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10) suggests Fpn is not removed from the phagosome via MVB formation.  If MVB 
formation was the mechanism of removal, I would expect to see Fpn retention on the 
phagosome during PI3K inhibition. Further, PI(3)P is required for sorting of proteins, 
such as EGFR, into MVBs (183). My data demonstrates that Fpn is absent from PI(3)P-
containing phagosomes (Fig 8) indicating that Fpn has been removed before sorting of 
proteins into MVBs occurs. However, to more conclusively demonstrate that Fpn is not 
removed via MVB formation, I could generate a Fpn mutant that does not get 
ubiquitinated, as has been done previously (124). This mutant should still be found on the 
phagosome since phagosomes are derived from bulk membranes. However, since 
ubiquitination is required for sorting of proteins into MVBs, if the Fpn mutant is still 
removed from the phagosome, I would be able to conclude that Fpn removal is not 
mediated by MVB formation.  
The finding that intracellular vesicles containing Fpn co-localize with LAMP1 
throughout the cell (Fig 4) has previously been reported (38, 195). The novelty in this 
finding is that Fpn is selectively excluded from LAMP1-containing phagosomes. It is 
possible that in our system, the vesicles containing Fpn that co-localize with LAMP1 may 
have been internalized via hepcidin found in the serum-containing media and has been 
targeted for degradation. Therefore, it is conceivable that our system consists of two 
distinct internalized populations of Fpn: the hepcidin-mediated internalized fraction and 
the phagocytosis-mediated internalized fraction.   
Overall, my findings also indicate that Fpn trafficking from the phagosome does 
not use the same mechanism as hepcidin-mediated internalization of Fpn. Recall, upon 
binding to hepcidin, Fpn is ubiquitinated (124), internalized and then trafficked through 
the MVB pathway (125) for lysosomal degradation (38). It is important to note that while 
phagocytosis and endocytosis share many common characteristics, notably endosomes 
and phagosomes undergo similar a maturation process, they represent distinct trafficking 
pathways within the cell and have many differences as well. For example, phagocytosis 
requires F-actin polymerization but does not require clathrin or dynamin, while 
endocytosis requires clathrin and dynamin but not actin polymerization (196). Another 
difference is that Fc"RIIA-mediated endocytosis requires ubiquitination, however 
Fc"RIIA-mediated phagocytosis does not (197, 198). Therefore, the differences between 
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the endocytic trafficking mechanism of Fpn and my data regarding phagocytic 
internalization of Fpn are likely attributable to the differences in internalization through 
endocytosis versus phagocytosis. Functionally, Fpn internalization due to hepcidin 
binding signals that the body is trying to prevent iron export from the cell (123). It 
follows that the result of hepcidin-mediated internalization is degradation of Fpn rather 
than recycling back to the plasma membrane as this would counter the effect of the initial 
internalization. Alternatively, in our model of phagocytosis, RAW cells are exposed to 
relatively constant levels of hepcidin which is assumed to be present in the serum the 
cells are maintained in. In phagocytosis, Fpn internalization was not a result of hepcidin 
signaling and so the cell may not need to degrade it. In fact, in concert with NO-
facilitated cellular increases in Fpn transcription in infected cells (121), the cell may 
recycle internalized Fpn back to the plasma membrane, possibly to aid in clearance of the 
intracellular bacteria. However, further investigation into this possibility is required.  
It is important to note that in images of late stage phagosomes (Fig 3, Fig 13), 
Fpn-positive phagosomes were present however infrequently. A possible explanation is 
that despite efforts to synchronize phagocytosis, we do not know when phagocytosis of a 
particular target began and thus certain phagosomes truly represent early stages of 
maturation at which point Fpn is still present. Two options exist to approach this 
problem. One option is to use live-cell imaging and follow the phagocytosis and 
phagosome maturation of individual targets. Alternatively, I could perform phagocytosis 
assays as described with one change in that I would add fluorophore-conjugated Abs at 
specific time points after addition of phagocytic targets and before fixation. By doing 
this, during imaging, if the phagocytic cargo is labeled with an antibody I will know that 
phagocytosis of that target began after the specified time point.  
Thus far, my evidence rules out the possibility that Fpn is excluded from the 
phagosome altogether as postulated at the outset of this study. Additionally, I have 
provided evidence that the phagosomal population of Fpn is not removed through 
degradative mechanisms, namely phagosome-lysosome fusion and MVB formation. The 
final proposed mechanism is recycling of Fpn back to the plasma membrane. Yet, when I 
compared Fpn localization to that of TfnR, a protein known to be retrieved to the plasma 
membrane (141), co-localization did not occur (Fig 6). I have also shown that unlike 
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TfnR, Fpn does not co-localize with the fast recycling mediator Rab4 (Fig 7) (141). It 
remains possible that Fpn is recycled through mechanisms other than those already 
investigated as the cell utilizes many additional mechanisms of recycling that warrant 
investigation. For example, it is of interest to investigate the role of Arf6 in Fpn removal 
from the phagosome. Arf6 is a small GTPase that regulates protein trafficking within the 
cell and functions at the plasma membrane where it is involved in recycling (199). Arf6 
has been shown to mediate the trafficking of many different proteins including: G-protein 
coupled receptors (200), MHC Class I (199), and $1 integrin (201). As such, Arf6 is 
another plausible candidate to investigate as a mediator of Fpn trafficking. Additional 
protein recycling mechanisms that warrant investigation include SNX17 (202) and the 
WASH complex (203).  
 In addition to investigating the recycling mechanisms discussed above, future 
work aims to examine more closely the relationship between Rab5 and Fpn, specifically 
regarding the Rab5 effector protein APPL1. APPL1 (adaptor protein containing PH 
domain, PTB domains and leucine zipper) is an adaptor protein originally discovered for 
its role in Akt signaling (204) and has been shown to bind to and modulate the signaling 
of a number of transmembrane receptors (205–207). Because of the co-localization 
observed between Fpn and Rab5 (Fig 11), of interest to this project is the role of APPL1 
as an effector protein of Rab5 (208). APPL1 is recruited to Rab5-containing phagosomes 
and, in cells expressing CA Rab5, APPL1 presence on the phagosome is prolonged (209). 
Further, it has been demonstrated that as PI(3)P accumulates on the phagosome, APPL1 
is lost (209). This is an interesting parallel to my findings that Fpn removal is delayed in 
cells expressing CA Rab5 (Fig 12) and also that Fpn is present on Rab5-positive 
phagosomes at 9 min (Fig 11) but not on PI(3)P-positive phagosomes at 10 min (Fig 8).  
Furthermore, APPL1 has been implicated in regulating trafficking of EGFR (207). Based 
on this evidence, APPL1 is a plausible candidate as a mediator of Fpn trafficking.  
Long term, it would be interesting to investigate if macrophages purposely 
remove Fpn from the phagosomal membrane to prevent iron supplementation to 
phagocytosed bacteria. Once mediators of Fpn trafficking are identified, presumably I 
could modulate Fpn localization to remain at the phagosomal membrane, possibly using 
dominant-negative constructs or RNA interference. Measurements of iron content in the 
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phagosome and inquiry into the rate of replication of intraphagosomal bacteria could be 
compared between Fpn-negative and Fpn-positive phagosomes to more clearly delineate 
the role Fpn removal plays in nutritional immunity.     
In summary, this study demonstrates that macrophages remove Fpn from the 
phagosomal membrane, likely to prevent extrusion of iron into the phagosomal lumen 
and thereby help limit bacterial growth inside the phagosome. This finding represents yet 
another possible mechanism whereby host cells restrict nutrient availability. Future work 
is needed to more clearly define the trafficking mechanism of Fpn internalized via 
phagocytosis to provide a more complete understanding of host innate immunity.  
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APPENDIX 1  
 
To establish that the Fpn-GFP fusion protein traffics correctly in RAW 
macrophages, I co-transfected RAW cells with plasmids encoding PM-RFP and Fpn-GFP 
and fixed the cells without adding a phagocytic target. I observed localization of both 
markers at the plasma membrane of RAW macrophages (Fig S1A) indicating Fpn 
trafficking throughout the cell is occurring properly. Next, I determined if Fpn-GFP over-
expression perturbed phagocyte function by evaluating the phagocytic capacity of Fpn-
GFP expressing cells or untransfected cells. To evaluate this, the average number of 
internalized beads for untransfected and transfected RAW macrophages after 1 hr 
incubation with IgG-opsonized beads was compared. Phagocytosed IgG-coated beads 
were differentiated from those that remained extracellular by staining with a fluorophore-
conjugated antibody (not shown). These experiments revealed that RAW macrophages 
with or without Fpn-GFP expression readily ingested IgG bearing targets, having a nearly 
identical phagocytic index of ~ 2.5 beads per cell (Fig S1B). 
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Figure S1. Fpn-GFP localizes to the plasma membrane and does not perturb 
phagocytosis in RAW264.7 macrophages. (A) RAW cells were co-transfected with 
PM-RFP (red) and pTF1 (green) and then fixed. Bar equals 20µm. (B) Graph depicts the 
average number of phagocytosed beads per cell in either untransfected RAW cells or 
RAW cells transfected with pTF1. Data are the mean ± SD derived from 3 independent 
experiments. Statistical significance was determined using an unpaired t-test, where n.s is 
not significant.   
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